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were more likely to undergo concomitant valve surgery and less likely to undergo CABG. 
Overall 30-day mortality was 9% for TV patients vs 3.5 % for non-TV patients (Table). 
Major Morbidity was 35% (TV) vs 16% (non-TV) (all p< 0.001).
Conclusions: Patients requiring TV interventions at the time of cardiac surgery have 
substantially higher mortality and morbidity than patients undergoing similar operations 
without tricuspid procedures. This ﬁnding suggests a need for quality improvement and 
research on the optimal management of patients with TV disorders.
Mortality after cardiac surgery with or without tricuspid intervention
Mortality 
without TV
Mortality 
with TV p-value
Composite
Morbidity
and Mortality 
without TV
Composite
Morbidity
and
Mortality 
with TV
p-value
MV 3.5% 6.9% <0.0001 17.2% 29.1% <0.0001
AV 3.7% 9.9% <0.0001 17.7% 38.3% <0.0001
CABG 2.4% 11.3% <0.0001 12.9% 37.3% <0.0001
MV+AV 8.1% 10.3% <0.0016 30.3% 41.3% <0.0001
MV+CABG 8.0% 11.0% <0.0001 33.3% 41.7% <0.0001
AV+CABG 5.9% 18.5% <0.0001 24.6% 45.8% <0.0001
MV+AV+CABG 12.9% 18.0% <0.0001 42.3% 54.5% <0.0001
Other 3.4% 6.8% 0.0184 29.2% 29.3% 0.9654
9:30 a.m.
1016-211 Failure to Prevent Ascending Aortic Dilatation by 
Mechanical Valve Replacement in Patients With 
Bicuspid Aortic Valve
Kevin P. Cohoon, Jillian Foley, Robert S. Dieter, Mamdouh Bakhos, Jeffrey Schwartz, 
Loyola University Medical Center, Maywood, IL
Background: The association between bicuspid aortic valve (BAV) and ascending aorta 
aneurysm is well described. However, the indication for replacement of the ascending 
aorta in conjunction with aortic valve replacement (AVR) remains controversial. Patients 
with moderate aortic dilatation (4.5-4.9 cm) have a greater risk of aortic complications. For 
this reason, replacement of the ascending aorta is now being considered at 4.5 cm. The 
purpose of this study was to help clarify at what diameter the aorta should be replaced 
in BAV patients.
Methods: We retrospectively identiﬁed consecutive patients who underwent elective 
aortic valve replacement with a mechanical ST. Jude Bioprosthesis from 1994-2000 at 
Loyola University Medical Center who were a 65 yrs of age at the time of surgery. Patients 
had a conﬁrmed diagnosis of BAV by echocardiogram, catheterization, intra-operative 
documentation, or surgical pathology. Patients returned for follow up imaging of their 
ascending aorta by CT angiography or echocardiography.
Results: 225 patients who underwent aortic valve replacement were identiﬁed. 59 
patients (26%) had a bicuspid aortic valve. 35 BAV patients (59%) returned for follow up 
imaging of their ascending aorta by CT angiography or echocardiography. The mean age 
at implant was 47 ± 13.5 years vs. 58 ± 13.4 years follow up. The mean follow up time 
was 7.2 ± 3.46 years. The mean diameter of the ascending aorta was 3.95 ± .83 (min 2.5-
max 6.4) cm. 7 patients (20%) had diameters classiﬁable as aneurismal (>4.5 cm) that 
developed within 9.6 ± 4.1 years from implant. 7 patients (12%) died in 5.9 ± 2.5 years 
from implant date with an age at implant of 61 ± 3.3 years with an implant size of 23.5 ± 
.97 mm. There was a correlation between aortic size and follow up time (Spearman’s rank 
order coefﬁcient of .3351, p=0.049).
Conclusions: Bicuspid aortic valves have a well described association with aneurysms 
of the ascending aorta and replacement alone does not prevent the progressive dilatation. 
In this series 20% of BAV patients demonstrated aneurysms >4.5 cm in a mean follow 
up of 9.6 years. We strongly recommend surgical repair of the ascending aorta at time of 
AVR for BAV be considered when diameter exceeds 4.0-4.5 cm.
9:30 a.m.
1016-212 Guideline or Geography: Which Determines Valve Type 
for Aortic Valve Replacement in Older Patients?
Eric Ehieli, Tara Karamlou, Brian S. Diggs, Wendy Walker, Kirk Caddell, Dodie De la Cruz, 
Ross M. Ungerleider, Karl F. Welke, Oregon Health & Science University, Portland, OR
Background: In 1998, the American College of Cardiology and the American Heart 
Association issued guidelines recommending the use of bioprosthetic (B) rather than 
mechanical (M) valves for aortic valve replacement (AVR) in patients >= 65 years. We 
sought to determine whether the choice of valve type for AVR in patients >=65 years 
varied by geographic region.
Methods: We identiﬁed all MAVR and BAVR in patients >= 65 years from 1997 to 2006 
in the Florida State Inpatient Database. Using small area analysis, patient zip codes were 
aggregated into hospital referral regions based on where patients were most likely to go 
for AVR. We then determined the regional rates of MAVR and BAVR.
Results: Of 26,229 AVR from 1997 to 2006, 16,529 were BAVR and 9,700 were MAVR. 
Statewide 37% of AVR in patients >=65 years were MAVR. Regional rates of MAVR 
varied widely, from 13.2% to 90.6%. (Figure) 
Conclusion: Valve choice for AVR in patients >=65 years varied greatly across geographic 
regions. MAVR use was very high in some areas, inconsistent with published guidelines. 
As valve selection is driven largely by physician choice, further studies should examine 
provider biases and preferences in an attempt to reduce this excessive variation.
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1016-209 Quality of Life Before and After Isolated Cardiac 
Surgery: Does the MAZE Procedure Offer the Greatest 
Improvement?
Kathleen L. Grady, Richard Lee, Haris Suba ius, S. Chris Malaisrie, Edwin C. McGee, 
Jr., Jane Kruse, Jeffrey Goldberger, Patrick M. McCarthy, Center for Atrial Fibrillation, 
Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Chicago, IL
Background: Our objective was to assess QOL after isolated cardiac surgical 
procedures.
Methods: 489 of 2,167 patients (pts) completed the Medical Outcomes Study 36-item 
Short Form Health Survey (SF-36); isolated procedures included: 85 coronary artery 
bypass graft (CABG), 48 mitral valve repair or replacement (MVR), 43 aortic valve 
repair or replacement (AVR), and 46 MAZE. Data were collected before and at 3, 6, 
and 12 months after surgery, and the physical component summary (PCS) and mental 
component summary (MCS) measures were analyzed using mixed effects models for 
QOL changes in time. Level of signiﬁcance was set at 0.05.
Results: (ﬁgure) At baseline, MVR pts had better PCS scores than the other groups, likely 
because of our practice of early repair, but there were no signiﬁcant changes over time. 
Baseline MCS scores of Maze pts were much lower at baseline (p<0.009), but the same 
as the other three groups at 6 months. MCS scores improved for all pt groups (p<0.039) 
except MVR (p=0.129). At 6 months, MCS stabilized for AVR and CABG pts but started 
to improve for Maze pts (p=0.002). Maze pts experience larger increase in PCS vs. MVR 
(p=0.022) group and MCS versus all others (p<0.027) from Baseline to 6-months.
Conclusions: Pts showed favorable PCS and MCS improvements after isolated cardiac 
surgery, but Maze pts had the most dramatic improvement. Baseline QOL should be 
a criterion to consider this therapy. Given these ﬁndings, surgical therapy may have a 
greater role in the future treatment of atrial ﬁbrillation.
9:30 a.m.
1016-210 Incremental Risks of Tricuspid Valve Procedures in the 
Society of Thoracic Surgeons Database
Richard Lee, J. S. Rankin, Shuang Li, Edwin C. McGee, Jr., S. M. O’Brien, S. C. 
Malaisrie, James S. Gammie, Patrick M. McCarthy, Northwestern University, Chicago, IL
Background: While the number of tricuspid valve (TV) procedures in North America has 
increased dramatically, few data are available to describe this population. The purpose 
of this study was to mortality/morbidity risks associated with the requirement of TV 
procedures.
Methods: Using STS database information from 2004 through 2007, 18,699 of 863,828 
patients had TV interventions. The incremental mortality of requiring an additional TV 
procedure was documented for multiple cardiac operations. Differences were evaluated 
using Mantel-Haenszel tests and Chi-square analyses.
Results: TV patients were more likely to be at the extremes of age, female (60% vs. 
31%), black (12% vs 6%), have renal disease, have congestive heart failure, and previous 
cardiac surgery (12% vs 6% prior CABG and 17% vs 2% prior valve). TV patients were 
less likely to be smokers, diabetic, obese, or have periperhal vascular disease. TV patients 
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1016-213 Prognostic Value of Geriatric Assessment Prior to 
Cardiac Surgery of the Elderly
Birgit Frilling, Wolfgang von Renteln-Kruse, Friedrich-Christian Riess, Albertinen- Haus; 
Center for Geriatric Medicine at the University of Hamburg, Hamburg, Germany, Heart 
Center, Department of Cardiac Surgery, Hamburg, Germany
Background: An increasing number of elderly patients develop cardiac disease requiring 
surgery. With the rise of new non-surgical treatment options, assessing operative risk has 
become one of the key aspects of clinical decision-making. Aim of this study is to evaluate 
the prognostic value of routine geriatric assessment (CGA) prior to cardiac surgery.
Methods: Interim analysis of a prospective cohort study. 160 consecutive patients who 
were referred for elective or urgent cardiac surgery underwent CGA on the day before 
surgery. Assessment included mobility (Timed up and go; TUG), handgrip strength (HS), 
cognitive function (DemTect), depression (Geriatric Depression Scale) and activities of 
daily life (ADL and IADL).
Results: Mean age was 76.1 years, mean STS-Score 14.7%. 52.5% of the patients had aortic 
valve replacement, 33.8% isolated coronary surgery. Hospital mortality was 3.75%. 40.6% 
of the patients had one or more postoperative complications (stroke, renal or heart failure, 
sepsis, delirium or new atrial ﬁbrillation); 27.9% had a prolonged hospital stay (LOS).
Conclusions: Low handgrip strength, impaired mobility and dependence in IADL are 
signiﬁcantly associated with postoperative death and proplonged hospital stay; HS is 
also associated with postoperative complications. CGA may add valuable information in 
assessing operative risk of elderly patients requiring cardiac surgery.
CGA and in-hospital events
Death
OR (95% CI)
Any complication
OR (95% CI)
LOS > 14 days
OR (95% CI)
Lowest quartile HS 12.6 (2.4-64.5) 3.1 (1.4-7.3) 4.3 (2.0-9.1)
TUG > 20 sec 13.3 (1.4-122) 1.2 (0.8-2.0) 2.4 (1.2-9.1)
Dependence in IADL 4.8 (1.03-22.7) 1.4 (0.9-2.1) 4.8 (2.5-9.6)
EF < 45 6.4 (1.2-33.7) 1.5 (1.06-2.2) 1.7 (0.9-3.0)
Renal failure 1.7 (0.3-9.0) 1.2 (0.8-1.8) 1.4 (0.7-2.6)
Age > 80 7.7 (1.5-40.2 1.5 (0.7-1.8) 2.0 (1.1-3.6)
9:30 a.m.
1016-214 New-Onset Atrial Fibrillation After Cardiac Surgery 
Associated With Differential Peripheral Leukocyte 
Expression Pathways
Tjorvi E. Perry, Basel Ramlawi, Cesario Bianchi, Jochen D. Muehlschlegel, Stanton K. 
Shernan, Simon C. Body, Frank Sellke, Beth Israel Deaconess Medical Center, Boston, 
MA, Brigham and Women’s Hospital, Boston, MA
Background: New-onset postoperative atrial ﬁbrillation (PoAF) after cardiac surgery is 
associated with signiﬁcantly increased morbidity and health care utilization. We compared 
preoperative gene-expression proﬁles in patients who developed PoAF after cardiac 
surgery with those who remained in sinus rhythm.
Methods: We prospectively matched patients who developed new-onset PoAF (n=11) after 
cardiac surgery and those who did not (n=13) based on pre-, intra-, and postoperative 
characteristics. Preoperative blood samples were analyzed for altered gene expression 
using Affymetrix U133 Plus 2 arrays. The ratios of transcript expression between groups 
were compared in the 30K genes analyzed. Pathway analyses were generated using 
Ingenuity Pathways Analysis (www.ingenuity.com).
Results: Of the transcripts exhibiting median ratio fold changes >1.35, 389 were 
upregulated and 1034 were downregulated in the PoAF group compared to the non-PoAF 
group. Patients with PoAF had signiﬁcant differential expression in the canonical pathways 
of glucocorticoid receptor, ERK/MAPK, protein ubiquitination pathway, P53 signaling and 
hypoxia signaling in the cardiovascular system.
Conclusion: Patients with PoAF exhibit markedly different gene expression proﬁles before 
undergoing cardiac surgery compared with matched patients who remained in sinus 
rhythm. Variations in these pathways, including genetic polymorphisms, may predict 
PoAF, and represent important therapeutic targets for PoAF. 
Top Canonical Pathways P-Value Genes
observed
%
upregulated
%
downregulated
Glucocorticoid Receptor 
Signaling
2.39E-
06 38 9.1 20
Hypoxia Signaling in the CV 
system
3.46E-
05 16 7 32.4
ERK/MAPK Signaling 3.06E-04 26 7.2 25
Protein Ubiquitination Pathway 5.26E-04 26 9.9 20.3
P53 Signaling 9.52E-04 16 12.6 23
Functions P-Value Genes
observed
Cell Death 3.20E-10 234
Post-Translational Modiﬁcation 3.20E-10 130
Gene Expression 2.26E-08 195
Cancer 3.52E-08 298
Hematological Disease 3.63E-08 100
Connective Tissue Disorders 7.97E-08 134
Inﬂammatory Disease 7.97E-08 106
Benjamini-Hochberg Multiple testing P-values
9:30 a.m.
1016-215 Impact of the Type of Prosthesis, Mechanical Versus 
Bioprosthesis, on Long-Term Survival Following Aortic 
Valve Replacement in Patients Younger Than 70 Years Old
Nicolas Girerd, Patrick Mathieu, Jean Dumesnil, François Dagenais, Pierre Voisine, 
Philippe Pibarot, Quebec Heart Institute, Quebec, QC, Canada
Background: The selection of the type of prosthesis (mechanical versus bioprosthesis) is 
still a matter of debate in patients undergoing aortic valve replacement (AVR), especially 
in those younger than 65-70 y.o. We sought to determine if the type of prosthesis is 
independently associated with long-term outcome following AVR.
Methods: We analyzed the preoperative, operative, and outcome data of 1091 
consecutive patients a70 y.o. undergoing AVR with or without CABG in our institution. 
Patients with endocarditis or aortic dissection were excluded.
Results: 161 deaths occurred during a mean follow up of 5.4 years (maximum 14). The 
336 patients (30.7%) with a mechanical valve were younger (57 ±8 vs. 64 ±6 years, 
p<0.001) but had similar prevalence of female gender, impaired LV ejection fraction, 
diabetes and hypertension compared to patients with a bioprosthesis (all p>0.10). 
Patients with a mechanical valve also had a higher prevalence (4.9% vs. 0.8%, p<0.001) 
of severe prosthesis-patient mismatch (PPM) deﬁned as an indexed prosthetic valve 
effective oriﬁce area < 0.65 cm2/m2. After adjustment for atrial ﬁbrillation, coronary artery 
disease, and signiﬁcant multivariate predictors of mortality, the utilization of a mechanical 
valve was associated with a signiﬁcant increase in the risk of cardiovascular mortality 
(HR=2.1, p=0.04) and tended to increase the risk of total mortality (HR=1.57, p=0.07). 
However, after further adjustment for severe PPM, mechanical valve implantation was 
no longer associated with increased cardiovascular or total mortality. Severe PPM was 
independently associated with a marked increase in cardiovascular and total mortality 
(HR=4.42 and HR=7.32, p<0.001). Conclusions: The implantation of a mechanical valve 
was associated with increased long-term cardiovascular mortality in patients a70 y.o. 
However, this difference was, in large part, explained by the higher prevalence of severe 
PPM in patients with a mechanical valve. In light of these results, the type of prosthesis 
does not appear to be an independent predictor of long-term survival after AVR in patients 
a70 y.o. These results also further emphasize the importance of avoiding severe PPM in 
this population.
9:30 a.m.
1016-221 Long-Term Outcomes Are Improved in Elderly Patients 
Undergoing Mitral Valve Repair Compared With Mitral 
Valve Replacement
Vinod H. Thourani, Robert A. Guyton, John D. Puskas, Patrick Kilgo, Omar M. Lattouf, 
Emory University, Atlanta, GA
Background: The most appropriate surgical management of elderly patients (pts) with 
severe mitral regurgitation remains controversial. The objective of this study was to 
compare the outcomes after MV Repair or Replacement in elderly pts.
Methods: Retrospective review of pts >75 years of age undergoing primary MV surgery from 
1996-2007 at an academic institution was performed. Pts were divided by MV Repair (n=76) 
or Replacement (n=131). Adjusted long-term survival was calculated using Cox proportional 
hazards model. Kaplan-Meier plots were used to determine 10-year survival rates.
Results: Mean age (Repair: 78.2±3.0 yrs vs. Replacement: 78.4±3.1 yrs, p=0.70) and 
male sex (Repair: 35/76, 46.1% vs. Replacement: 57/131, 43.5%, p=0.83) were similar 
between groups. Concomitant CABG was similar between groups: Repair (39/76, 
51.3%) vs Replacement (61/131, 46.6%, p=0.67). EF% was higher in pts undergoing 
Replacement (53.7±14.0% vs 49.8±13.0, p=0.03). The median LOS was 8 days for both 
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groups (P=NS). In-hospital survival was similar between groups: Repair (70/76, 92.1%) vs 
Replacement (113/131, 86.3%, p=0.30). 10-yr survival was higher in Repair pts (49.0% vs 
21.2%, p=0.01). 10-yr survival in Repair pts with (48.5%) or without (52.0%) CABG were 
higher than Replacement with (28.3%) or without (13.8%) CABG (p=0.01).
Conclusions: In elderly pts, short-term survival is similar between MV Repair or 
Replacement. However, pts undergoing MV repair had improved long-term survival when 
compared to Replacement. 
9:30 a.m.
1016-222 Preoperative Renin-Angiotensin System Inhibitors 
Protect Renal Function in Aging Patients Undergoing 
Cardiac Surgery
Jian-Zhong Sun, Viachaslau Barodka, Scott Silvestry, Said Shariﬁ-Azad, James Diehl, 
Zvi Grunwald, Thomas Jefferson University, Philadelphia, PA
Background: Increasing numbers of elderly patients with more advanced cardiac 
diseases and comorbidities have been referred for cardiac surgery. For these patients, 
renal dysfunction or failure represents a major postoperative complication and there has 
been no effective clinical therapy to prevent it.
Methods: A retrospective study was performed on all patients (n = 1287) receiving 
cardiac surgery at this institution from August 2003 to December 2007. The patients 
included were q65 yr old, without preexisting renal failure and scheduled for elective 
cardiac surgery (mainly coronary artery bypass graft or valve surgery). Renal failure was 
deﬁned as increase of serum creatinine more than 2.0 mg/dL, doubling preoperative 
creatinine level or a new requirement for dialysis postoperatively.
Results: Of all patients, 346 patients met the inclusion criteria and were divided into 
2 groups: using (n=122) or not using (n=224) preoperative RAS inhibitors including 
angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers. When 
comparing these 2 groups, there were no signiﬁcant differences in baseline parameters 
including creatinine clearance, body mass index, history of diabetes and smoking, 
preoperative using beta-blockers, statins and aspirin; in intraoperative perfusion and aortic 
cross-clamp time, and in postoperative complications including atrial ﬁbrillation, cerebral 
vascular accident, prolonged mechanical ventilation and 30 days mortality except that 
the patients with RAS inhibitors were found more with history of hypertension (90.2% 
vs 75.9%, P<0.001), congestive heart failure (14.8% vs 8.0%, P<0.05) but less with 
chronic lung disease (28.7% vs 39.3%, P<0.05). However, preoperative RAS inhibitors 
signiﬁcantly and independently reduced the incidence of postoperative renal failure in the 
patients undergoing cardiac surgery when compared with without ones: 1.6% (2 out of 
122) vs 7.6% (17 out of 224) (P<0.02), and yielded a relative risk of 0.22 (95 % conﬁdence 
interval 0.06-0.82).
Conclusions: These results demonstrate that preoperative RAS inhibitors have signiﬁcant 
renoprotective effects for aging patients undergoing cardiac surgery.
9:30 a.m.
1016-223 Abbreviated Time Course for Left Ventricular 
Hypertrophy Regression and Remodeling Imparted by 
Aortic Valve Replacement for Severe Aortic Stenosis: A 
Cardiovascular MRI Study Sponsored by the American 
Heart Association
Robert W. Biederman, James A. Magovern, Saundra B. Grant, Ronald B. Williams, June 
A. Yamrozik, Diane A. Vido, Vikas K. Rathi, Mark Doyle, Allegheny General Hospital, The 
Gerald McGinnis Cardiovascular Institute, Pittsburgh, PA
Background In pts with severe aortic stenosis (AS), long term data tracking surgically 
induced beneﬁcial effects on reverse LV remodeling are not available. Echocardiographic 
data is available short term, but in limited fashion beyond a year. Cardiac MRI (CMR) 
offers the ability to track long term changes in LV metrics with small numbers due to its 
inherent high spatial resolution and low variability.
Hypothesis We hypothesize that changes following aortic valve replacement (AVR) are 
detectable by CMR and such changes in LV structure and function, triggered by AVR, 
continue for an extended period post AVR.
Methods Ten pts (67±12 yrs, 6 female) with severe, but compensated, AS underwent 
CMR pre and post AVR at 6±2mo, 1yr±2mo, and up to 4yrs±5mo. LV mass index (LVMI), 
LV geometry, volumetrics and EF were measured (GE, 1.5T, Milwaukee, WI). A Kruskall-
Wallis one-way ANOVA was performed.
Results All 10 pts survived AVR and underwent CMR at up to 4 years (40 time points). 
LVMI markedly decreased at 6 months (157±42 to 134±32g/m2, p<0.005), continuing 
to trend down at 4 yrs (127±32g/m2). Similarly, EF increased pre to post AVR (55±22 
to 65±11%, (p<0.05)) and continued trending upward, remaining stable at years 1-4 
(66±11 vs. 65±9%). LVEDV index, initially high pre AVR, normalized post AVR (83±30 
to 68±11ml/m2, p<0.05), trending even lower by yr 4 (66±10 ml/m2). LV stroke volume 
increased rapidly from pre to post AVR (40±11 to 44±7ml), continuing to increase at 4 
yrs (49±14ml, p=0.3). Most importantly, LVMI/volume, a 3D measure of LV geometry, 
remained unchanged initially but over 4 yrs markedly improved (1.07±0.2 to 0.94±0.24, 
p<0.05), all paralleling improvements in NYHA (3.2±1.0 to 1.5±1.1, p<0.05).
Conclusion After initial beneﬁcial effects imparted by AVR in severe AS patients, there 
are, as expected, marked improvements in LV reverse remodeling. , Via CMR, we show 
that surgically induced beneﬁts to LV structure and function, including favorable alterations 
in LV geometry, are durable and unexpectedly, show continued improvement through 4 
years post AVR concordant with sustained improved clinical status. This suggests down-
regulation of both mRNA and MMP activity acutely with robust suppression long term.
9:30 a.m.
1016-224 Predicting In-hospital Mortality Following 
Cardiovascular Surgery Using the Texas Heart Institute 
Risk Score
Saurabh Sanon, Sreedevi Gondi, Vei-Vei Lee, MacArthur A. Elayda, James M. Wilson, 
The University of Texas Health Science Center, Houston, TX, The Texas Heart Institute 
at St. Luke’s Episcopal Hospital, Houston, TX
Introduction: Preoperative risk prediction models are an integral part of current surgical 
intervention for comparing operator outcomes, risk assessment, counseling and cost-
beneﬁt analysis. The purpose of this study was to develop a risk scoring technique for 
predicting in-hospital mortality for all patients admitted for cardiovascular surgery.
Methods: Using data from the Texas Heart Institute Research Database, we analyzed 
outcomes of 21,467 patients admitted for cardiovascular surgery from 1995-2007. Our 
outcome was early mortality, deﬁned as death within 30 days of surgery or in-hospital 
mortality. Multivariate logistic regression identiﬁed mortality predictors using 14,836 
patients from 1995 -2001 (derivation set, DS). Risk scores were developed by multiplying 
the beta coefﬁcient of each predictor by a constant and rounding to the nearest integer. 
Patients were stratiﬁed, using additive risk scores, into 3 groups: low risk (LR; score <10), 
medium risk (MR; score <20) and high risk (HR; score >20). Scores were validated on 
6,631 patients from 2002-2007 (validation set, VS).
Results: Signiﬁcant predictors of mortality included, urgent surgery within 48 hours of 
admission, advanced age, renal insufﬁciency, coronary artery bypass graft surgery (CABG), 
redo-CABG, concomitant aortic aneurysm repair or vascular surgery and preoperative intra-
aortic balloon pump. Predicted mortality from the DS in LR, MR and HR groups were 1.4%, 
3.5% and 15.5% respectively. Observed DS mortality was 1.1%, 3.5% and 16.0% in the LR, 
MR and HR groups respectively. VS predicted mortality in the LR, MR and HR groups were 
1.5%, 3.7% and 15.9%. Observed mortality was 0.6%, 2.5% and 10.5% in the LR, MR and 
HR groups respectively. The DS-VS divergence validates the need for recalibration and shows 
that previous uncalibrated models may not be valid in contemporary populations due to non 
uniform distribution of procedure subtypes and development of better surgical technique.
Conclusion: Our study identiﬁes patients at greater risk of early mortality following 
cardiovascular surgery. We showed remodeling using new data or recalibration of old 
models is warranted to maintain applicability of risk scoring models.
9:30 a.m.
1016-225 The Society of Thoracic Surgery Risk Model Accurately 
Predicts Survival and Perioperative Complications 
Following High-Risk Aortic Valve Replacement
Henry A. Tran, Scott Barnett, Sharon Hunt, Niv Ad, Inova Fairfax Hospital, Falls Church, VA
Background: Several risk models exist to predict operative outcomes following 
cardiac surgery and are utilized in selecting patients for alternative procedures such as 
transcatheter valve implantation. We sought to evaluate the performance of the Society 
of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) model in accurately 
identifying patients at high risk for aortic valve replacement (AVR).
Methods: 466 consecutive patients who underwent isolated aortic valve replacement 
from January 1, 2001 to July 1, 2008, at a tertiary care center were analyzed using 
the STS database. Patients were stratiﬁed into tertiles according to operative surgical 
risk calculated by the STS-PROM (0-5%;5-10%;>10%). Vital status at one year was 
determined using the National Death Index and Social Security Death Index.
Results: There were 372 low-risk patients (average age 64.3± 11.7), 65 intermediate-
risk patients (average age 76.9 ± 9.3) and 29 high-risk patients (average age 72.9 ± 
14.4). The predicted risk of death for low-risk, intermediate-risk, and high-risk groups 
were: 2.4%±1.1%, 6.9± 1.4%, and 15.8 ± 7.6% respectively. Observed operative mortality 
for each respective group was: 1.6%, 4.6%, and 13.8% (p<0.001). 1 year survival was 
92.5%, 76.9%, and 75.5 % (p<0.001) respectively. The 1 year survival of intermediate 
and high-risk octogenarians was not signiﬁcantly different than younger patients. The STS 
risk model was found to accurately predict perioperative morbidities such as perioperative 
stroke and renal failure.
Conclusions: High-risk patients have signiﬁcantly increased mortality following AVR. 
The STS-PROM very accurately predicts operative mortality, morbidity as well as 1 year 
survival. . Patients having AVR using traditional or percutaneous techniques should be 
evaluated using the STS-PROM.
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1016-226 Local Inﬂammatory Activation Within the Aortic Valves 
of Patients With Nonrheumatic Aortic Valve Stenosis: 
First In Vivo Experience in Humans
Maria Drakopoulou, Konstantinos Toutouzas, Andreas Synetos, Eleftherios Tsiamis, 
Dimitrios Iliopoulos, Stergios Theodoropoulos, Magdi Yacoub, Dimitrios Tousoulis, 
Christodoulos Stefanadis, First Department of Cardiology, Hippokration Hospital, 
Athens, Greece
Background:Histological studies have demonstrated a potential role of inﬂammation 
in aortic valve stenosis (AVS). We investigated in patients with AVS whether there is 
1) temperature difference between the leaﬂets and the ascending aortic wall and 2) a 
possible correlation between heat production and inﬂammation.
Methods: We examined 96 leaﬂets from 32 patients scheduled for aortic valve 
replacement: 25 with AVS and 7 with aortic valve insufﬁciency (AVI). Temperature 
measurements were performed before hypothermic cardioplegia. Temperature difference 
($T) was assigned as the mean temperature of each aortic leaﬂet minus the temperature 
of the aortic wall. Histological analysis was performed and analyzed semiquantitatively.
Results: In AVS leaﬂets, $T was greater compared with AVI (noncoronary: 1.09±1.16 
vs. 0.10±0.10°C; right: 1.24±1.03 vs. 0.02±0.19°C; left: 1.53±1.23 vs. 0.05 ±0.19°C; p 
<0.01 for all comparisons). Dense lymphocyte inﬁltration was observed in 97.8% of AVS 
versus 0% of AVI (p < 0.01). Increased inﬁltration from mast cells and calcium deposit 
was detected in all leaﬂets from AVS versus none from AVI (p<0.01). Mean $4 in leaﬂets 
with intense calcium deposit, lymphocyte and mast cell inﬁltration, was greater compared 
to leaﬂets with low (1.33±1.11 vs, 0.002±0.25°C p<0.01; 1.33±1.11 vs, 0.002±0.25°C 
p<0.01; respectively) (Figure A,B,C).
Conclusions: Thermal heterogeneity is increased in AVS and correlates with inﬂammatory 
cell inﬁltration and calcium deposit.
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3:30 p.m.
1025-209 Acute Kidney Injury Network (AKIN) Criteria: Renal 
Dysfunction After On-pump Coronary Artery Bypass 
Surgery
Mauricio N. Machado, Rafael C. Miranda, Isabela T. Takakura, Eduardo Palmegiani, 
Osana M. Mouco, Mauro E. Hernandes, Maria Angélica B. Lemos, Lilia N. Maia, São 
José do Rio Preto Medical School, São José do Rio Preto, Brazil
Background: Acute kidney injury (AKI) is a complex disorder for which, currently, there 
is no standard deﬁnition accepted. AKIN (Acute Kidney Injury Network) represents an 
attempt to standardize the criteria for diagnosis and staging of acute renal dysfunction 
based on RIFLE criteria (Risk, Injury, Failure , Loss, and End-stage kidney disease), 
published recently. The objective os this study is evaluate the incidence and mortality 
associated with AKI (based on the AKIN criteria) in patients undergoing on-pump 
coronary artery bypass grafting (CABG) surgery.
Methods: From January 2003 to January 2008, 1151 patients were underwent CABG, 
and 817 with cardiopulmonary bypass (CPB). These patients were divided into two 
groups: AKI (-) with 421 patients (51.5%) and AKI (+) with 396 patients (48.5%). AKI 
was deﬁned as an absolute increase in serum creatinine (SCr) of more than or equal to 
0.3 mg/dl (q 26.4 μmol/l) or a percentage increase in SCr of more than or equal to 50% 
(1.5-fold from baseline).
Results: The average age was 61 ± 9 years and 567 patients (70%) were male. Patients 
AKI (+) were older (60 ± 9.5 years vs. 62 ± 9.0 years, p = 0.04), had higher rates of 
diabetes mellitus (31% vs. 39%, p = 0.02 ) and was predominantly female (26.6% vs. 
35.0%, p = 0.01). The average lengh of stay in ICU was 3.4 ± 4.0 days vs. 6.0 ± 9.5 
days - p <0.0001 and a greater proportion of patients AKI (+) had prolonged stay in ICU 
(> 14 days) - 2% vs. 14%, p <0.0001. The 30-day mortality of patients AKI (+) was 12.6% 
compared with 1.4% of patients AKI (-) [p <0.0001; RR 8.9 (95% CI - 4 to 20); power to 
5% signiﬁcance > 99.99% and the population attributable risk - 79%]. Area under ROC 
curve for the presence of AKI and death was 0.72 (95% CI - 0.67 to 0.76) with a sensitivity 
of 89%, speciﬁcity 54% and negative predictive value of 99%. In a multivariate logistic 
regression model, AKI after on-pump CABG was an independent predictor of 30-day 
mortality (p = 0.0002; OR 6.7 - 95% CI - 2.5 to 18.2).
Conclusion: In this population, even a slight change of renal function based on AKIN 
criteria was an independent predictor of 30-day mortality. This group of patients had 
greater ICU lengh of stay and higher rates of prolonged hospitalization (> 14 days) in 
ICU.
3:30 p.m.
1025-210 Changes of Mitral Valve Conﬁgurations After Restrictive 
Annuloplasty in Functional Mitral Regurgitation With 
Isolated Annular Dilatation
Kunitsugu Takasaki, A. Marc Gillinov, Tetsuhiro Yamano, Hiroki Oe, Roberto M. Saraiva, 
Takahiro Shiota, Cleveland Clinic Foundation, Cleveland, OH
Background: Clinical importance of mitral valve conﬁgurations in ischemic mitral 
regurgitation (MR) has been reported. We sought to evaluate the valve conﬁguration 
before and after restrictive annuloplasty in functional MR patients with isolated annular 
dilatation.
Methods: This study consisted of 23 consecutive lone AF patients who had undergone 
restrictive annuloplasty for functional MR. Patients with left ventricular dilatation, systolic 
dysfunction, or organic mitral valve disease were excluded. Mitral annular area/body 
surface area (BSA), anterior (AML) and posterior mitral leaﬂet (PML) angles relative to 
the mitral annular plane, and coaptation length/BSA (Figure) were quantiﬁed by 2-D echo 
before and early after surgery. MR severity was assessed by the vena contracta width.
Results: Of the 23 patients, 20 (87%) had no detectable MR and the rest of 3 (13%) 
had only trace MR after surgery. MR severity was signiﬁcantly decreased (5.1 to 0.3 
mm, p<0.0001). Mitral annular area/BSA was decreased and coaptation length/BSA 
was increased signiﬁcantly after surgery (5.7 to 2.6 cm2/m2, 1.4 to 4.7 mm/m2, p<0.0001, 
respectively). AML angle was signiﬁcantly decreased (23 to 17 degrees, p<0.001), while 
PML angle was signiﬁcantly increased (36 to 73 degrees, p<0.0001).
Conclusion: Restrictive mitral annuloplasty eliminates MR with increasing coaptation 
length and improvement of anterior tethering, but not of posterior tethering, in functional 
MR with isolated annular dilatation. 
3:30 p.m.
1025-211 Effect of Mitral Valve Repair on Left Ventricular Function 
and Geometry in Patients With Degenerative Mitral 
Regurgitation And Left Ventricular Ejection Fraction > 60%
Mustafa I. Ahmed, James D. Gladden, Steven G. Lloyd, Himanshu Gupta, Seidu Inusah, 
Thomas S. Denney, Jr., David C. McGifﬁn, Louis J. Dell’Italia, University of Alabama at 
Birmingham, Birmingham, AL, Auburn University, Auburn, AL
Background: Optimal timing of surgery for chronic severe degenerative mitral 
regurgitation (MR) is controversial with current guidelines recommending surgery if left 
ventricular ejection fraction (LVEF) is a 60%. We investigated the effect of mitral valve 
repair (MV-rep) on LV function and geometry 1-year post surgery in MR patients with 
pre-surgical LVEF >60%.
Methods: Fifteen consecutive patients with chronic MR and LVEF >60% were evaluated 
immediately prior to, and 1-year post MV-rep by three-dimensional magnetic resonance 
imaging with tissue tagging. Forty healthy subjects acted as controls.
Results: All patients had successful MV-rep surgery as manifest by no or only trivial MR 
post-MV-rep. Mean LVEF, which did not differ signiﬁcantly from normal (65±1%) pre-MV-
rep, decreased signiﬁcantly below normal post-MV-rep (66±1 vs. 57±1, p<0.01). Although 
not differing signiﬁcantly from normal prior to MV-rep, there were decreases below normal 
following MV-rep in peak circumferential strain (11.2±0.5 VS. 13.8±0.3 %, p<0.01) and 
strain rate (0.57±0.03 vs. 0.66±0.02 %/%RR, p<0.01) along with longitudinal strain (9.7±0.6 
vs. 12.2±0.4 %, p<0.01) and strain rate (0.56±0.04 ± 0.66±0.03 %/%RR, p<0.05). Mean
LV-end diastolic (LVED) volume index (Normals, 66±3) decreased from 108±5 to 79±6 
ml/m2 post-MV-rep, however LV-end systolic (LVES) volume index (Normals, 23±1mm) 
did not fall signiﬁcantly post-MV-rep (37±3 to 36±5 mm). When compared to those with 
LVEF < 55% following surgery (mean LVES volume index 53±7 ml/m2), those patients 
with post-operative LVEF > 55% (mean LVES volume index 24±2 ml/m2) had signiﬁcantly 
lower pre-operative LVES-dimension (47±4 vs. 40 ±2 mm, p<0.05) and LVED-dimension 
(66±2 vs. 60±2 mm, p<0.05).
Conclusions: Despite pre-MV-rep LVEF > 60%, chronic MR patients showed LV 
impairment and persistent adverse LV geometry 1 year post-MV-rep. MR patients with 
a greater degree of LV dilation pre-MV-rep were more likely to have LV impairment and 
adverse LV geometry post MV-rep. These results suggest that in order to best preserve 
LV function and structure, timing of surgery for chronic MR should be guided by degree of 
adverse remodeling even if LVEF is apparently well preserved.
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1025-212 Assessment of Regional Circumferential Myocardial 
Stress Before and After Stringent Restrictive Mitral 
Annuloplasty for Dilated Cardiomyopathy With 
Multidetector Computed Tomographic Angiography and 
Novel Software System
Koji Takeda, Goro Matsumiya, Hajime Matsue, Yasuhiro Shudo, Koichi Toda, Kazuhiro 
Taniguchi, Yoshiki Sawa, Osaka University Graduate School of Medicine, Suita, Japan, 
Japan Labour Health and Welfare Organization, Osaka Rosai Hospital, Sakai, Japan
Background. Recent studies indicate that stringent restrictive mitral annuloplasty (RMA) 
could reduce left ventricular (LV) wall stress in dilated cardiomyopathy with functional 
mitral regurgitation. We investigated the end-systolic regional wall stress (ESS) before 
and after RMA using newly developed software and multidetector computed tomographic 
angiography (MDCTA) images.
Methods. MDCTA was performed in 22 patients (mean LV ejection fraction 27 ± 
8.7%) before and after RMA. For image analysis, 2 and 4 chamber cine images were 
reconstructed throughout one cardiac cycle. Images were transferred to the software 
and ESS was automatically calculated by the Jan’z formula at 12 areas. End-systolic 
pressure was measured by means of calibrated carotid pulse tracing at the time of image 
acquisition.
Results. End-diastolic and systolic volumes decreased from 240±55 to 202±59 ml 
(p=.002) and from 186±79 to 138±67 ml (p=.01), respectively. LV ejection fraction 
improved from 27±8.7 to 36±14% (p=.001). ESS decreased at each area, remarkably at 
anterior and septal area (Fig; *P<.01). Representatively, there was a signiﬁcant inverse 
correlation between change in ejection fraction and in mid anterior ESS (seg 2) (r=-0.65, 
p<0.0001), suggesting that RMA may reduce ESS and lead to a favorable improvement 
of LV ejection performance.
Conclusion. The present data suggest that our newly developed software using MDCTA 
images may be useful to assess relationship between ESS and LV performance before 
and after RMA. 
3:30 p.m.
1025-213 Characteristics of Patients With Severe Calciﬁc Aortic 
Stenosis but Normal Coronary Arteries
Sachin S. Goel, Akin Cam, E Murat Tuzcu, Samir R. Kapadia, Cleveland Clinic, 
Cleveland, OH
Background: Although coronary artery disease (CAD) is often present with severe calciﬁc 
aortic stenosis (AS), it is not uncommon to encounter severe AS without signiﬁcant CAD.
Aim: We sought to identify the prevalence and determinants of angiographically 
insigniﬁcant (<30% stenosis) CAD in patients with severe AS.
Methods: A total of 443 consecutive patients with severe (AVA a 1 cm2) AS who 
underwent cardiac catheterization between 2004 and 2007 were identiﬁed from the 
hospital database. Patients with bicuspid, rheumatic or radiation AS were excluded
Results: Non-signiﬁcant CAD was present in 71 (16%) patients. No identiﬁable 
angiographic irregularities (normal coronaries) were seen in 24 (5.4%) patients. Patients 
with insigniﬁcant CAD were younger and more frequently women (Table). Hypertension 
and hyperlipidemia were more frequent in patients with CAD. On multivariate analysis, 
predictors of insigniﬁcant CAD were female gender [OR (odds ratio) 2.0, 95% CI 
(conﬁdence interval) 1.1-3.6, p=0.01], absence of hyperlipidemia [OR 2.3, CI 1.1-4.6, 
p=0.02] and absence of hypertension (OR 1.8, CI 0.89-3.62, p=0.09). Similar results were 
obtained when patients with angiographically normal coronaries were analyzed.
Conclusion: One sixth of patients with severe calciﬁc AS have angiographically 
insigniﬁcant coronary atherosclerosis. Female gender, absence of hyperlipidemia and 
lack of HTN are predictors of insigniﬁcant CAD in patients with severe calciﬁc AS. 
Characteristics
Signiﬁcant CAD
(q30%
obstruction)
(n=371)
No signiﬁcant 
CAD
(<30%
obstruction)
(n=72)
P value
Age
Male (%)
Body Mass Index (kg/m2)
Hypertension (%)
Diabetes (%)
Hyperlipidemia(%)
Smoking history(%)
Peripheral arterial disease (%)
76 ± 8
70
24 ± 11
86
33
87
54
28
73 ± 10
51
25 ± 11
75
29
71
45
8
0.007
0.003
0.57
0.02
0.54
0.001
0.18
0.001
Total Cholesterol (mg/dL)
LDL (mg/dL)
HDL(mg/dL)
Triglycerides (mg/dL)
163 ± 42
89 ± 35
52 ± 16
118 ± 61
167 ± 37
89 ± 29
54 ± 15
120 ± 82
0.53
0.95
0.51
0.83
Statin use (%) 72 57 0.01
Aortic valve area (cm2)
Peak gradient (mm of Hg)
Mean gradient (mm of Hg)
Ejection fraction (%)
Moderate or severe Mitral annular 
calciﬁcation (%)
0.7 ± 0.2
68 ± 24
39 ± 16
49 ± 14
33
0.7 ± 0.1
79 ± 23
46 ± 13
54 ± 12
29
0.16
0.0004
0.001
0.02
0.48
3:30 p.m.
1025-214 Impact of Obesity on Left Ventricular Hypertrophy in 
Patients With Asymptomatic Aortic Stenosis. A SEAS 
Substudy
Barbara P. Lund, Christa Gohlke-Baerwolf, Dana Cramariuc, Anne B. Rosseboe, Aashild 
E. Rieck, Eva Gerdts, Haukeland University Hospital, Bergen, Norway
Background: Obesity and hypertension (HT) are associated with left ventricular 
hypertrophy (LVH). Whether increased body mass index (BMI) is associated with LVH in 
patients with asymptomatic aortic stenosis independent of HT, is not known.
Methods: Clinical blood pressure (BP), BMI and echocardiographic variables were recorded 
at baseline in 1,717 patients with asymptomatic aortic stenosis, recruited in the Simvastatin 
Ezetimibe in Aortic Stenosis (SEAS) study. Patient population was divided into three BMI 
classes: normal BMI<25.0 kg/m2, overweight BMI 25.0-29.9 kg/m2 and obese BMIq30.0 kg/m2.
Results: In the total study population average BP was 145/82+/-20/10 mmHg, age 67+/-
10 years, BMI 26.8+/-4.3 kg/m2, and peak transaortic velocity 3.1+/-0.5 m/sec. With 
increasing BMI class, 43.1% versus 51.1% versus 63.0% had HT. Left ventricular mass 
increased with higher BMI, while ejection fraction decreased. The prevalence of LVH was 
20.8% in normal, 37.5% in overweight and 54.0% in obese patients (p<0.01 between 
groups). In multiple logistic regression analysis higher BMI was associated with higher 
prevalence of LVH independent of history of HT, age, systolic BP, left ventricular ejection 
fraction and peak transaortic velocity (all p<0.05). Valve regurgitation and gender had no 
independent association with presence of LVH.
Conclusions: Higher BMI predicts LVH in patients with asymptomatic aortic stenosis 
independent of other known covariates of LVH.
Odds ratio 95% conﬁdence interval Signiﬁcance
BMI (kg/m2) 1.15 1.12-1.19 <0.001
Age (years) 1.01 1.00-1.03 0.030
Hypertension (y/n) 1.27 1.01-1.61 0.042
Systolic blood pressure (mmHg) 1.01 1.01-1.02 <0.001
Left ventricle ejection fraction (%) 0.95 0.94-0.96 <0.001
Peak transaortic velocity (m/sec) 1.86 1.52-2.28 <0.001
3:30 p.m.
1025-215 Usefulness and Feasibility of Aortic Valve Repair 
Utilizing an Autologous Pericardium for the Patients 
With Severe Aortic Stenosis
Takenori Otsuka, Makoto Suzuki, Tsukasa Osaki, Takako Tsuchida, Hiromasa 
Yamashita, Yasuhiro Ozeki, Makoto Uchida, Shigeyuki Ozaki, Kaoru Sugi, Toho 
University Ohashi Medical Center, Tokyo, Japan
Background: Elderly calciﬁed stenotic aortic valves are usually replaced by the 
bioprosthetic valve. We report our experiences to repair the stenotic aortic valve using 
aortic valve repair technique.
Methods: Thirty-one patients underwent aortic valve repair. Patients characteristics is 
as follows ; mean age was 74±8, aortic valve area : 0.80±0.19cm2, pressure gradient 
between left ventricle and the aorta : 78.6±27.5mmHg, left ventricular ejection fraction 
: 67±12%. Aortic valve repair was performed by our unique technique which created 
individual aortic valve utilizing an autologous pericardium. Perioperative evaluations 
performed by both transesophageal and transthoracic echocardiography.
Results: There was no early mortality. Degree of postoperative aortic regurgitation was 
non in 16 cases, trivial in 14 cases and mild in 1 case. Peak systolic pressure gradient 
across the aortic valve was 16.5±8.4 mmHg after repair. No patient underwent reoperation 
for any reasons. Peak systolic gradient was signiﬁcantly lower in aortic valve repair group 
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compared with aortic valve replacement group using bioprosthetic valve with or without 
stent. (16.5±8.4 vs 29.2±10.5, respectively, p<0.0001, Figure).
Conclusions: Aortic valve repair is safe and feasible to the patients with severe aortic 
stenosis. Furthermore, residual pressure gradient across the aortic valve is signiﬁcantly 
lower compared with valve replacement. 
3:30 p.m.
1025-221 Oxidized LDL: A Marker Of Rapid Progression In Aortic 
Stenosis
Miquel Gomez, Lluis Molina, Mercedes Cladellas, Montserrat Fito, Maribel Covas, 
Cristina Roqueta, Jordi Bruguera, Hospital del Mar. Universitat Autonoma Barcelona, 
Barcelona, Spain, Institut Municipal Investigacio Medica, Barcelona, Spain
Background: Some studies have proposed several markers of rapid progression in aortic 
stenosis (AS) with divergent ﬁndings.
Objectives: To analyse the role of biomarkers of rapid progression in aortic stenosis
Material and methods: Prospective study of 155 patients with moderate to severe AS. 
We determined as possible markers of rapid progression: C Reactive Protein (hs-CRP) 
, oxidized LDL cholesterol (oxLDL), Creatinine, Phosphorus-calcium product (PxCa), 
calcitonyne, paratohormone (PTH). We considered as slow progressors: patients with 
reduction of Aortic Valvular Area (AVA) lower than 0.05 cm2 and/or increase in Maximal 
Velocity lower than 0.15 m/s. Rapid progressors were: patients with reduction in AVA more 
than 0.05 cm2 and/or increase of Aortic Velocity >0.15 m/s in a 6-month period.
Results: Mean age was 76(5.1) years, 54% were women. Echocardiographic 
parameters: Mean Gradient 43.2 (16) mmHg, Aortic Valve Area 0.79(0.13) cm2 and AVA 
Index 0.48(0.16) cm2/m2. 48 patients (31%) showed rapid progression. Mean CRP was 
5,71 (7.9) mg/dl, oxLDL 48.8 (32.2) mg/dl, calcitonyne 4.27 (7.2) pg/ml, creatinine 1.05 
(0.8) mg/dl, PTH 69.9 pg/ml (52). In multivariate analysis oxLDL were related to rapid 
progression (p=0.01). CRP, renal function, PxCa, calcitonyne and PTH were not related 
to progression velocity (pNS).
Conclusions: OxLDL was a marker of rapid haemodynamic progression velocity in 
patients with moderate to severe AS. We have found no independent relationship with 
other suggested markers. 
3:30 p.m.
1025-222 The Relation Between Systemic Vascular Resistance, 
Aortic Compliance and Transvalvular Pressure 
Gradients in Patients With Severe Isolated Valvular 
Aortic Stenosis and Preserved or Depressed Left 
Ventricular Systolic Function
Tanya Dutta, Florentina Petillo, Jing Han, Nathaniel Reichek, Eddy Barasch, St. Francis 
Hospital/SUNY at Stony Brook, Roslyn, NY
Background: In about 30% of patients (pts) with severe aortic stenosis (AS) and 
preserved left ventricular ejection fraction (EF), the transvalvular mean gradients (MG) 
are <30 mm Hg whereas in a number of pts with similar severity of AS but low EF, the MG 
are > 30 mm Hg. We hypothesized that systemic vascular resistance (SVR) and aortic 
compliance (AC) may explain the discrepancy between MG and EF values for a given 
severity of AS in pts with normal and low EF.
Methods: 214 pts with normal EF (mean age 77+/-10 yrs, 49% males, EF = 64+/-9%, SVR 
19.5+/-5.9 dyne.cm.sec -5 , AC = 1.10+/-0.47 ml/mm Hg, aortic valve area index -AVAi- = 
0.39+/-0.01 cm2/m2) and 46 pts (Group2) with low EF (mean age, 80+/-11yrs, 66% males, 
EF = 36+/-10%, SVR 17.9+/-8.8, dyne.cm.sec -5 , AC = 0.99+/-0.43ml/mm Hg, AVAi = 0.42+/-
0.2 cm2/m2) underwent comprehensive 2-D echo exam. All pts were in normal sinus rhythm 
and had isolated AS. To correct for AS severity, the analyses were adjusted for 4 indices of 
stenosis (see table) using the multiple regression. Partial r2 and p values were reported. 
Results: The correlation between MG, and SVR and AC adjusted for indices of AS 
severity are illustrated below: 
Systemic vascular resistance Aortic Compliance
Analysis adjusted for Normal EF
r2
Low EF
r2
Normal EF
r2
Low EF
r2
AVAi 0.17p<0.0001 NS
0.05
p =0.02 NS
LV stroke work loss NS NS 0.05p = 0.03 NS
Energy loss index 0.21p<0.0001
0.20
p=0.007
0.05
p =0.02 NS
Aortic valve resistance 0.06p =002
0.49
p <0.0001 NS
0.16
p=0.01
Conclusions: 1. Both SVR and AC contribute to the discrepancies between MG and 
AS severity in both EF groups. 2. The strongest association was found between MG and 
SVR adjusted for aortic valve resistance in the low EF group which may explain relative 
high MG in some of these pts. 3. The interpretation of MG in severe AS should take into 
consideration SVR and AC.
3:30 p.m.
1025-223 Compensatory or Inappropriate Left Ventricular Mass in 
Asymptomatic Aortic Stenosis
Giovanni Ciofﬁ, Giovanni de Simone, Dana Cramariuc, Gian Francesco Mureddu, Eva 
Gerdts, University of Bergen and Haukeland University Hospital, Bergen, Norway
Background: In some patients with aortic stenosis (AS) left ventricular (LV) mass growth 
exceeds what is needed to sustain the haemodynamic load imposed by the combination 
of valve impedance and vascular resistance. This condition named inappropriate LV mass 
is associated with increased risk of postoperative mortality after aortic valve replacement. 
Prevalence and factors associated with inappropriate LV mass have been assessed in 
hypertensives, but are unknown in AS. 
Methods: we analyzed baseline, clinical and echocardiographic data from 1614 
patients (67±10 years, 51% hypertensive) recruited in the Simvastatin Ezetimibe in 
Aortic Stenosis (SEAS) study evaluating placebo-controlled combined simvastatin and 
ezetimibe treatment in mild-moderate AS. Inappropriate LV mass was diagnosed by 
Doppler echocardiography when the measured LV mass > 28% of the expected value 
predicted from height, sex and stroke work. Individual severity of AS was assessed by 
energy loss index. LV systolic function was assessed by midwall shortening. 
Results: inappropriate LV mass was detected in 268 patients (16.6%), the prevalence 
being similar in patients with and without hypertension (18 vs 15%, p = ns). LV systolic 
dysfunction was detected in 256 patients with inappropriate LV mass (97%). Despite similar 
blood pressure and valve area, in patients with inappropriate LV mass the myocardial LV 
afterload measured as end-systolic stress / ejection fraction ratio was slightly lower than 
patients with appropriate LV mass. In multivariate analysis inappropriate LV mass was 
independently associated with lower midwall shortening, lower LV afterload, greater LV 
mass, higher LV relative wall thickness and body weight (sensitivity 72%, speciﬁcity 96%, 
area under the ROC curve for the best model in the identiﬁcation of iLVM = 0.954). 
Conclusions: inappropriate LV mass is common in patients with asymptomatic AS and 
is unrelated to the severity of valve disease and hypertension. In particular, inappropriate 
LV mass was associated with combined concentric geometry and reduced LV myocardial 
contractility, suggesting inappropriate LV mass in asymptomatic AS as a marker of more 
advanced myocardial disease.
3:30 p.m.
1025-224 Carotid Arterial Stiffness Classiﬁes Diastolic 
Dysfunction in Mitral Regurgitation
Kiyomi Niki, Motoaki Sugawara, Itaru Takamisawa, Hiroyuki Watanabe, Tetsuya 
Sumiyoshi, Saichi Hosoda, Tomoki Shimokawa, Hitoshi Kasegawa, Shuichirou 
Takanashi, Himeji Dokkyo University, Sakakibara Heart Institute, Musashi Institute of 
Technology, Tokyo, Japan
Background: Echocardiographic indices of diastolic function in mitral regurgitation (MR) 
are controversial because regurgitant ﬂow modiﬁes Doppler indices. Increased arterial 
stiffness is reported to have correlation with LV diastolic dysfunction. The purpose of this 
study was to evaluate the association between arterial stiffness and Doppler indices of 
LV diastolic function in MR.
Methods: We measured carotid arterial stiffness parameter, B, using echo-tracking 
system, and echocardiographic indices before surgery in 94 sinus rhythm patients with 
MR (61 men, age 52±14 yrs) in whom surgical treatment was indicated.
Results: Mean B was 13.8±5.7. We divided the whole group at the mean B into two 
subgroups: the increased carotid arterial stiffness group having B>14 (Group H: n=41, 
age 62±9 yrs) and the group having B<14 (Group L: n=53, age 44±12 yrs, p<0.001 vs age 
of Group H). The main echocardiographic data are given in the table. Group H showed 
increased LA volume/LVEDV, increased LVSW, increased E/e’, reduced e’ and higher RV 
systolic pressure, all of which are considered to be the signs of deterioration of diastolic 
function, compared with Group L. There were no differences in LV ejection fraction, 
LVEDVI, LA volume, E/A, ERO and regurgitant fraction.
Conclusion: Indices of diastolic function before surgery, except for E/A and LA volume, 
deteriorated in the group with higher carotid arterial stiffness in MR, which suggests the 
association of carotid arterial stiffness with diastolic function in MR.
Group L 
(B<14)
Group H 
(B>14)
LA volume[cm3] 71.8±22.4 82.2±28.5 n.s.
LA volume/LVEDV 0.79±0.26 0.97±0.30 p=0.0052
LV septal wall thickness (LVSW) [cm] 0.95±0.11 1.02±0.11 p<0.0032
E/A 2.2±0.7 1.9±0.8 n.s.
Early diastolic mitral inﬂow to tissue velocity 
(E/e’) 12.0±4.7 16.1±5.2 p=0.0002
e’ [cm/s] 11.1±2.5 8.0±1.9 p<0.0001
RV systolic pressure [mmHg] 36.2±10 46.8±16 p=0.0004
Effective regurgitant oriﬁce area (ERO) [cm2] 0.50±0.16 0.49±0.17 n.s.
Regurgitant fraction [%] 54.5±8.1 56.2±8.8 n.s.
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3:30 p.m.
1025-225 Surgical and Percutaneous Aortic Valve Replacement 
Have Different Impact on Diastolic Phase in Elderly 
Patients With Aortic Valve Stenosis
Fabio Guarracino, Sonia Petronio, Enrica Talini, Marco De Carlo, Cristina Giannini, 
Maurizio Stefani, Fabiola Lapolla, Rubia Baldassarri, Vito Di Bello, University Hospital of 
Pisa, Pisa, Italy
Background: percutaneous aortic valve replacement (pAVR) has been proposed as an 
option for high-risk pts with severe symptomatic aortic valve stenosis (AVS) to minimize 
the overall surgical trauma. Diastolic dysfunction is a typical feature of severe aortic valve 
stenosis. Perioperative complications of surgical aortic valve replacement (sAVR), such 
as respiratory and renal insufﬁciency, are related to diastolic dysfunction. We aimed to 
investigate the effect of pAVR on LV diastolic function and to compare it to sAVR.
Methods: twenty pts with symptomatic severe AVS ( aortic valve area <1 cm2), an 
age q75 years with a logistic EuroSCORE q20%, scheduled to undergo pAVR were 
included. LV diastole was evaluated basally (T1) and after the valve implantation (T2) 
with echocardiography by LV ﬂow propagation velocity (Vp) and mitral annulus velocities 
measurement. An age-matched control group of 20 pts undergoing surgical AVR for AVS 
was evaluated intraoperatively in the some way before (T1) and after AVR (T2). Data 
were analysed for statistical signiﬁcance by Student t-test. A p<0.05 was considered for 
signiﬁcance.
Results: pAVR group showed an acute change in diastolic phase consisting in signiﬁcant 
increase of Vp (29 cm/sec at T1 vs 40 cm/sec at T2, p<0.05), and of mitral annular E’ (4.6 
cm/sec at T1 vs 6.5 cm/sec at T2, p<0.05). Control group showed a signiﬁcant reduction 
of both Vp (36 cm/sec at T1 vs 28 cm/sec at T2, p<0.05) and E’ (4.8 cm/sec at T1 vs 3.2 
cm/sec at T2, p<0.05).
Conclusions: Vp and E’ increase suggest that pAVR may acutely improve LV diastolic 
phase, whereas Vp and E’ decrease suggest that sAVR leads to worsening of diastolic 
dysfunction. Preservation of diastolic function during percutaneous approach for AVR 
may play a major role in lowering perioperative morbidity and mortality in such high risk 
patients.
3:30 p.m.
1025-226 Prevalence of Carcinoid Heart Disease Increases 
During Follow-Up
NIcolas Mansencal, Emmanuel Mitry, Jean-Baptiste Bachet, Philippe Rougier, Olivier 
Dubourg, Hôpital Ambroise Paré, AP-HP, Boulogne, France
Background: Carcinoid heart disease (CHD) is a rare disease and its prevalence is 
uncertain. The aim of this prospective study was to assess the prevalence of right-sided 
and left-sided CHD. 
Methods: We prospectively studied 60 consecutive patients referred to our institution 
for histologically proven digestive endocrine tumor and carcinoid syndrome. All patients 
underwent serial conventional transthoracic echocardiographic studies and biological 
carcinoid markers. Right-sided and left-sided CHD and score of severity of CHD (0-30) 
were systematically assessed.
Results: Mean duration of follow-up was 28 months (range, 12 to 60 months). At baseline, 
prevalence of right-sided and left-sided CHD was 33% and 8%, respectively, whereas at the 
end of follow-up, this prevalence was respectively 52% and 22% and was similar in the ﬁrst 
30 patients included as compared with the last 30 patients included (p =0.80 and p =0.69, 
respectively). Mean global score of gravity was 13.1 ± 6.9 in patients with CHD. Correlations 
were strong between urinary 5-HIAA and right-sided CHD score (r = 0.72, p < 0.0001), 
between urinary 5-HIAA and left-sided CHD score (r = 0.79, p = 0.001) and between urinary 
5-HIAA and global CHD score (r = 0.81, p < 0.0001). All patients with at least 3 years of 
carcinoid syndrome and increased level of urinary 5-HIAA presented with CHD. 
Conclusions: Prevalence of right-sided CHD remains high and left-sided involvement 
was observed even more frequently than previously reported. Carcinoid heart disease 
progresses over time, highlighting the need for echocardiography once the diagnosis of 
carcinoid syndrome is made.
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1034-209 Natural History of Aortic Valve Disease Following 
Interventions for Rheumatic Mitral Valve Disease
Amit Sharma, Gaurav Verma, Milind phadke, Charan Lanjewar, Prasanna Nyayadheesh, 
Prafulla Kerkar, Cardiology Department King Edward Memorial (KEM) Hospital, 
Mumbai, India
Background:A signiﬁcant proportion of patients who require interventions for rheumatic 
mitral valve disease have co-existing aortic valve disease. Little is known about the natural 
history of aortic valve disease (AVD) in these patients.
Methods:We retrospectively reviewed a cohort of 400 patients with rheumatic heart 
disease, who had index mitral valve procedure (IMP), either closed or balloon mitral 
valvotomy or mitral valve replacement during 1995 to1997, and had long term regular 
follow up. Clinical and echocardiographic data at entry and on follow up were noted. .
Results: Patients were grouped in to group I who had no AVD at baseline (196/400 
patients) and group II who had AVD at baseline (204/400 patients). AVD was categorized 
as thickening only (Group II A), isolated aortic regurgitation (AR) (Group II B), or combined 
aortic stenosis (AS) and AR (Group II C). Mean follow up period was 9.3 to 10.7 years. 
From Group I, 20 patients developed new AVD, which included 4 pts with aortic valve 
thickening only, 2 with mild AS and trivial AR, and 14 patients had trivial-mild AR. From 32 
patients in the group II A, 22 patients developed isolated AR, and one progressed to have 
mild AS and AR. From 138 patients in group II B, 44 (31.9%) developed AS on follow up, 
and all had mild (16) or moderate (28) AR with mild AS. Group II C had 34 patients and 
one each had moderate AS and moderate AR. Of 32 patients with mild AS, 12 progressed 
to moderate AS and two to severe AS requiring AVR. AR became moderate in 20 patients 
and severe in one patient. On logistic regression analysis of the variables predisposing 
to progression of AVD like age, sex, history of rheumatic fever (RF) and recurrence, 
interval from RF episode to symptom onset etc, only initial AS gradient was identiﬁed as 
statistically signiﬁcant (Beta coefﬁcient 0.528, SE 0.17, p < 0.0001). Only four patients 
required AVR on follow up. Patients with rheumatic mitral valve disease with no or mild 
AVD at the time of mitral valve surgery do have minor progression of AVD, and seldom 
require aortic valve surgery over long term follow up.
Conclusions: Presence of mild AS at baseline is a potential indicator of rapid progression 
of AVD, which demands a closer monitoring during follow-up.
9:30 a.m.
1034-210 Echocardiographic Evidence of Signiﬁcant 
Regurgitation Can Be the Sole Criterion for Diagnosis 
of Probable Rheumatic Heart Disease: Experience from 
a Large Cross-Sectional Survey
Maneesha Bhaya, Raja B. Panwar, Rajesh Beniwal, Sadiak Panwar, Sardar Patel Medical 
College, Bikaner, India, National Institute of Occupational Health, Ahmedabad, India
Background: The prevalence of rheumatic heart disease (RHD) in India has been 
estimated based on school surveys to identify the burden of disease. RHD has been 
diagnosed in school surveys based on presence of auscultatory ﬁndings. Cardiac 
auscultation might not have been sensitive enough to detect all the cases of RHD. The 
role of echocardiography in detecting left sided regurgitations not audible by cardiac 
auscultation has been accepted. We tested the performance of World Health Organization 
(WHO) criteria of probable RHD in a supposedly low prevalence geographical area on a 
randomly selected group of school children.
Methods: We randomly selected 31 clusters from the coeducational schools of Bikaner city. We 
selected 1059 children aged 6-15 years. All of them underwent a complete echocardiographic 
examination by a single operator, which was conﬁrmed by second expert independently.
Results: We identiﬁed seven children with congenital heart disease and 41children 
having mitral valve prolapse. These were excluded from the analysis. Out of 1011 school 
children, 53 cases of probable RHD could be detected by echocardiography. None of these 
children had audible murmur. One case was having higher grade of mitral regurgitation 
and we were able to clinically diagnose RHD in that child. The prevalence of probable 
RHD stood at 52.4 per 1000,which is quite high. The prevalence of RHD among boys 
(n=606) was not different from that detected in girls (n=404). Thus, clinical auscultation 
as a tool to diagnose RHD may have been underestimating the burden of disease in the 
population. Mild thickening of valve leaﬂets was found in 15 per 1000 cases. No other 
morphologic evidence of RHD was found. We found that morphological criteria suggestive 
of an echocardiographic diagnosis of RHD may not coexist with signiﬁcant regurgitation 
in about 21% of the cases.
Conclusion: We report a high prevalence of probable RHD. WHO criteria for the diagnosis 
of probable RHD are easy to apply. We found that morphologic criteria could not be relied 
upon for echocardiographic diagnosis of RHD.
9:30 a.m.
1034-211 Immediate and Long-Term (Up to 18 Years) Results of 
Mitral Balloon Valvuloplasty in Patients With Extreme 
Pulmonary Hypertension
Mohamed Eid Fawzy, Hani Sergani, Bahaa Fadel, Maie Shahid, Abdulaziz Al Ghamdi, 
Mohammed Kandeel, Shabir Shah, King Faisal Heart Institute, Riyadh, Saudi Arabia
Background: Mitral stenosis (MS) with extreme pulmonary hypertension constitutes 
a high risk subset for surgical commissurotomy or valve replacement. Mitral balloon 
valvuloplasty (MBV) emerged as the treatment of choice for patients with severe pliable 
MS. The efﬁcacy of this procedure in patients with extreme pulmonary hypertension has 
not been fully elucidated in particular the long-term outcome.
Methods: Mitral balloon valvuloplasty (MBV) was successfully performed in 531 consecutive 
patients. Of these 38 (7%) patients had extreme pulmonary hypertension at baseline (group 
A) (deﬁned as pulmonary artery pressure (PAP) at rest > 75% of systemic arterial pressure) 
were analyzed and compared with remaining 493 patients (group B) the control group .
Results: Patients in group A had higher echo score and were more symptomatic and the 
majority had moderate to severe tricuspid regurgitation (61%). The left atrial pressure in 
group A was 27.3 ± 5.3 mmHg vs 25.9 ± 4.7 mmHg in group B (P = 0.098) and mean 
mitral gradient 14.5 ± 2.2 mmHg vs. 14.4 ± 2.0 mmHg (P = 0.62) smaller baseline MVA 
0.7 ± 0.16 m2 vs. 0.85 ± 0.19 (P < 0.0001) and higher pulmonary vascular resistance 
853 ± 384 vs. 228 ± 197 dyne/sec/cm-5 (P < 0.0001), smaller post procedure MVA 1.66 ± 
0.43 vs. 1.83 ± 0.53 cm2 (P = 0.046). PAP decreased signiﬁcantly 6-12 months after MBV 
from 90 ± 12.5 to 38 ± 18 mm Hg (P<0.0001) and severe TR regressed. Kaplan Meier 
estimates of freedom from restenosis in group A at 10 and 15 year were 68% ± 1% and 
35% ± 1% vs. 77% ± 2%, 47% ± 3% in group B respectively (P = 0.036) and event free 
survival at 10 and 15 years 76% ± 10% and 45% ± 15% vs. 88% ± 4% and 54% ± 4% for 
group B respectively (P = 0.039).
A410  ABSTRACTS - Valvular Heart Disease JACC March 10, 2009
Va
lv
ul
ar
 H
ea
rt
 D
is
ea
se
Conclusions: MBV is safe and effective technique in treating patients with MS and 
extreme pulmonary hypertension. Immediate results are comparable, however long-term 
results are slightly inferior compared to the control group with regression or normalization 
of pulmonary hypertension and concomitant severe tricuspid regurgitation.
9:30 a.m.
1034-212 A Randomized Clinical Trial of Once Versus Twice Daily 
Gentamicin Dosing Regimen for Infective Endocarditis
Kristine Buchholtz, Carsten T. Larsen, Bente Schaadt, Jens O. Lund, Christian 
Hassager, Niels E. Bruun, Gentofte University Hospital, Copenhagen, Denmark
Background: Infective endocarditis (IE) patients often receive gentamicin for a prolonged 
period of time and it is recommended that gentamicin is administered twice or trice rather 
than once a day. But there is no clinical evidence supporting a multi dosage regimen and 
once daily gentamicin dosing is recommended for treatment of a number of other serious 
infections. Therefore we have undertaken a study in IE patients on the effects of once vs. 
twice daily gentamicin dosing on renal function and measures of the infectious disease. 
Methods: IE patients (n=71) needing gentamicin treatment according to guidelines were 
randomized to either once (n=37) or twice daily (n=34) doses of gentamicin. Gentamicin 
doses were adjusted according to daily se-creatinine and trough se-gentamicin values. 
Kidney function (glomerular ﬁltration rate (GFR)) was measured with an isotope method 
(51Cr-EDTA (Chromium-EthyleneDiamineTetraacetic Acid)) at the beginning of treatment 
and again at discharge. Efﬁcacy of treatment was assessed by measuring time to T½ of 
plasma C-reactive protein (CRP), mean daily plasma CRP and leucocytes concentrations 
during hospitalization and different measures of treatment failure.
Results: Baseline GFR was similar in the two groups. Both groups displayed a signiﬁcant 
fall in GFR from admission to discharge; the once daily gentamicin group fell 17.0 % 
(95% CI 7.5-26.5) and the twice daily gentamicin group 20.4 % (95% CI 12.0-28.8). There 
was however no signiﬁcant difference in the GFR fall between the once and twice daily 
regimens (p=0.573). No difference was demonstrated in infection parameters between 
the two dosing regimens.
Conclusions: Twice daily gentamicin dosing regimen is neither less nephrotoxic nor 
more efﬁcient that the once daily gentamicin dosing regimen in treatment of IE patients. 
When indicated gentamicin may therefore be administered as a single dose regimen, also 
in treatment of IE patients.
9:30 a.m.
1034-213 Cardiac Risk in Asymptomatic Severe Aortic Stenosis 
Patients Undergoing Non-Cardiac Surgery
Anna M. Calleja, Subha Dummaraju, Rakesh Gaddam, Stephen Cha, Bijoy K. 
Khandheria, Hari P. Chaliki, Mayo Clinic, Scottsdale, AZ, Mayo Clinic, Rochester, MN
Background: Severe Aortic Stenosis (AS) is recognized as a signiﬁcant predictor of 
cardiac risk in non cardiac surgery. Patients with severe symptomatic AS require aortic 
valve replacement and postponement of non cardiac surgery as per the recent ACC/AHA 
guidelines. However, management of patients with severe asymptomatic AS undergoing 
non cardiac surgery is not clear due to paucity of prior studies and conﬂicting results. 
Speciﬁcally, it is unclear whether these patients should ﬁrst undergo aortic valve surgery 
or proceed directly to non cardiac surgery.
Methods: Among 602 patients with AS who underwent non cardiac surgery between 
1998 and 2007, 30 consecutive patients (cases) with severe asymptomatic AS (valve area 
< 1 cm2) were compared to 60 age and gender matched (1:2) control patients with mild 
to moderate AS. Mean age of the group was 77 ±8 years (68% males). Majority of cases 
(73.4%) and controls (58%) underwent intermediate to high risk surgical procedures 
(vascular surgery, orthopedic surgery, urologic surgery, and intra-abdominal surgery).
Results: Combined post operative events (death, myocardial infarction, heart failure, 
ventricular arrhythmias, and hypotension requiring vasopressors) were signiﬁcantly 
higher in cases (43%) when compared to controls (23%) (P=0.05). However, most of the 
events were intra-operative hypotension episodes requiring vasopressors which were two 
and half times more likely in cases (37%) when compared to controls (17%) (Odds ratio of 
2.5; CI 1.02-8.05) (P=0.04). Myocardial infarction was not signiﬁcantly different between 
cases and controls (6.7% vs. 3.3% respectively; P= 0.57). There were no post operative 
deaths or heart failure events in cases or controls.
Conclusions: 1) Non-cardiac surgery in patients with severe asymptomatic AS can be 
performed with an acceptable risk most likely due to improvement in anesthetic techniques 
and meticulous peri-operative care. 2) Intra-operative hypotension is very frequent in 
patients with severe AS and needs to be treated promptly and aggressively.
9:30 a.m.
1034-214 Aortic Valve Calciﬁcation Is Associated With the 
Presence, Extent and Composition of Coronary Artery 
Plaque: ROMICAT Substudy
Amir A. Mahabadi, Fabian Bamberg, Michael Toepker, Michael D. Shapiro, Ian S. 
Rogers, John T. Nagurney, Thomas J. Brady, Udo Hoffmann, Quynh A. Truong, Cardiac 
MRI PET CT Program, Massachusetts General Hospital, Harvard Medical School, 
Boston, MA
Background: Aortic valve calciﬁcation (AVC) is associated with cardiovascular risk factors 
and coronary artery calciﬁcation. We aimed to determine whether AVC is associated 
with the presence and extent of overall plaque burden, as well as to plaque composition 
(calciﬁed, mixed, and non-calciﬁed).
Methods: We examined 361 subjects (mean age: 53 ± 12 years, 62% male) who 
underwent contrast-enhanced ECG-gated 64-slice multidetector computer tomography 
from the ROMICAT study for (1) the assessment of presence and extent of coronary 
plaque burden according to the 17-coronary segment model and (2) presence of AVC, as 
determined by two experienced readers. In a subgroup analysis of subjects with presence 
of AVC, the AVC volume was derived by the modiﬁed Simpson’s method using dedicated 
volumetric software by summation of manually measured region of interest.
Results: Subjects with AVC (n=39, 11%) were more likely than those without AVC (n=322, 
89%) to have coexisting presence of any coronary plaque (90% vs. 47%, p<0.001) and had 
a greater extent of coronary plaque burden (6.5 ± 4.2 segments vs. 2.0 ± 3.0 segments, 
p<0.001). After adjustment for traditional cardiovascular risk factors, those with AVC had 
over 3-fold increase odds of having any plaque (odds ratio [OR] 3.6, 95% conﬁdence 
interval [CI] 1.0-12.4, p=0.046) and an increase of 2.3 segments of plaque (95% CI 1.3-3.3, 
p<0.01) as compared to those without AVC. When stratiﬁed by plaque composition, AVC 
was associated most with calciﬁed plaque (OR 5.3, 95% CI 1.7-16.3, p=0.004), followed by 
mixed plaque (OR 3.3, 95% CI 1.3-8.7, p=0.01), and was not associated with non-calciﬁed 
plaque (p=0.99). In the subgroup with AVC, AVC volume had moderate correlation to the 
extent of plaque (r=0.48, p=0.002), but varied depending on composition (calciﬁed: r=0.34, 
p=0.04; mixed: r=0.31, p=0.056) with no correlation to non-calciﬁed plaque (p=0.99).
Conclusions: AVC is a marker of overall coronary artery plaque burden and may be 
part of the later stages of the atherosclerosis process, as it is associated strongest with 
calciﬁed plaque, less with mixed plaque, and not with non-calciﬁed plaque.
9:30 a.m.
1034-215 Relation of Degree of Aortic Valve Calciﬁcation to 
Left Ventricular Geometry and Systolic Function in 
Asymptomatic Aortic Valve Stenosis: A SEAS Substudy
Dana Cramariuc, Giovanni Ciofﬁ, Christa Golke-Bärwolf, John B. Chambers, Terje R. 
Pedersen, Ronnie Willenheimer, Kristian Wachtell, Eva Gerdts, Institute of Medicine, 
University of Bergen, Bergen, Norway, Haukeland University Hospital, Bergen, Norway
Background: Signiﬁcant aortic valve calciﬁcation (AC) has been identiﬁed as a powerful 
predictor of outcome in aortic stenosis (AS). Less is known about its relation to left 
ventricular (LV) geometry and systolic function in asymptomatic AS.
Methods: AC was assessed on 1725 baseline echocardiograms in the Simvastatin 
Ezetimibe in Aortic Stenosis (SEAS) study. AC was scored as none (no calciﬁcation), mild 
(small isolated spots), moderate (multiple larger spots) or severe (extensive calciﬁcation 
of all cusps). Severity of AS was deﬁned by the energy loss index (ELI), systemic arterial 
compliance by stroke volume/pulse pressure, and LV systolic function by stress-corrected 
midwall shortening (low if <89.2%).
Results: 1464 (85%) patients had AC (18% mild, 29% moderate, 38% severe). Patients 
with severe AC were more often men, had lower stress-corrected midwall shortening and 
ELI, and more LV hypertrophy and concentric geometry (all p <0.05). In logistic regression 
analysis, severe AC was associated with higher LV mass, more concentric LV geometry, 
and lower ELI, independent of systemic arterial compliance, age or hypertension (Table). 
In a subsequent model, low stress-corrected midwall shortening was also signiﬁcantly 
associated with severe AC (OR 1.42, p<0.05).
Conclusions: In asymptomatic patients, severe AC is associated with echocardiographic 
features predicting poorer prognosis (higher LV mass, concentric LV geometry, low LV 
systolic function) independent of the severity of AS itself. 
Table. Odds ratios for continuous variables are per one standard 
deviation increase
Severe AC
Variable Odds ratio 95% CI P
Male gender (%) 1.29 0.88-1.90 0.19
Age (years) 1.05 0.87-1.26 0.63
History of hypertension (%) 0.71 0.50-1.01 0.06
LV mass (g) 1.35 1.10-1.65 0.005
Concentric LV geometry (%) 1.21 1.01-1.46 0.04
Energy loss index (cm²/m²) 0.22 0.18-0.27 <0.001
Systemic arterial compliance (ml/ mm Hg) 0.92 0.76-1.10 0.34
9:30 a.m.
1034-221 Paravalvular Leak Reduction After Transcatheter Aortic 
Valve Replacement With Self Expandable Biological 
Prosthesis
Gian Paolo Ussia, Marco Barbanti, Sarah Mangiaﬁco, Massimiliano Mulè, Marilena 
Scarabelli, Valeria Cammalleri, Sebastiano Immè, Salvo Scandura, Corrado Tamburino, 
Catania, Italy
Background:Percutaneous aortic valve replacement (PAVR) with CoreValve self-
expandable prosthesis has shown to be safe and effective technique for high-risk and 
inoperable patients with severe symptomatic aortic valve stenosis (AVS). Preliminary 
results have been evaluated as event-free survival, but no data are available about 
any predictors for mid-term procedural success yet. The aim of this study is to evaluate 
sphericity index and paravalvular leakages as echocardiographic tools of CoreValve 
prosthesis functionality assessment.
Methods: From April 2007 until August 2008, 38 consecutive patients (18 male; mean 
age 81±5) with AVS underwent PAVR. Of these, 30 patients with successfully prosthesis 
implantation had more than 6 months follow-up. Prosthesis functionality and positioning 
(longitudinal/transversal axis ratio and paravalvurar leakages) have been assessed by 
transthoracic echocardiogram after 48 hours, at 30-day and at 6 months.
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Results: After the procedure overall patients had a marked upgrading in hemodynamic and 
echocardiographic parameters (peak-to-peak gradient from 64±23 to 2±0,4; p<0,001. Aortic 
Valve Area Index from 0,3±0,1 to 0,9±0,3; p<0,001). At 30 days 4 patients had a prosthesis 
longitudinal/transversal axis ratio >1, which was associated to paravalvular leakage grade 
2+. Moreover, 23 had grade 1+ aortic regurgitation. After 6 months grade 2+ of paravalvular 
leakage was not present in any patients, and the longitudinal/transversal axis ratio was 1 in 
all patients. Aortic regurgitation decreased from grade 1+ to 0 in 16 patients.
Conclusions: Our preliminary results indicate that CoreValve prosthesis optimizes its 
deployment even during 6 months after the implantation. Echocardiographic sphericity 
index and paravalvular leakages evaluation are useful to assess the functionality of self-
expandable aortic valve prosthesis.
9:30 a.m.
1034-222 Mitral Regurgitation: Long-Term Survival and Impact of 
Severity and Pulmonary Artery Systolic Hypertension
Matthew W. Parker, Murray A. Mittleman, Carol A. Waksmonski, Marilyn F. Riley, Warren 
J. Manning, Beth Israel Deaconess Medical Center, Boston, MA
Background: The impact of pulmonary artery (PA) systolic hypertension (HTN) on 
long-term (>10 year) survival in patients with mitral regurgitation (MR) has not been 
described.
Methods: Our institution’s electronic echocardiography database was queried to identify 
those patients examined in 1992 with at least mild MR. Patients were grouped into Gp 1) 
mild; Gp 2) mild-to-moderate and moderate; and Gp 3) moderate-to-severe and severe 
MR. PA pressure (mm Hg) was categorized as normal (35). 2008 mortality data were 
obtained from the Social Security Death Index. Age-stratiﬁed Cox proportional hazards 
modeling compared survival times among groups and adjusted for sex, mitral valve 
prolapse, ﬂail mitral leaﬂet, and depressed LVEF (<55%).
Results: Of 4984 echo reports in 4050 patients, 2025 patients (50%) were identiﬁed with 
at least mild MR. Overall survival was 30% at 15 years. Crude survival was greatest in Gp 
1. Hazard ratios (95% CI) for Gp 2 and Gp 3 compared to Gp 1 were 1.07 (0.94-1.21) and 
1.45 (1.22-1.72). Depressed LVEF carried a hazard ratio of 1.67 (1.49-1.87). Moderate or 
greater PA HTN was a signiﬁcant risk factor (HR 1.52; 95% CI 1.30-1.79), but borderline 
and mild PA HTN were not signiﬁcant risk factors. (Figure)
Conclusions: Long-term (15 yr) survival of patients with at least mild MR is only 30% 
and inversely related to the severity of MR. Moderate or greater PA HTN, in addition to 
depressed LVEF, identiﬁed those at highest risk. 
9:30 a.m.
1034-223 Disease-Speciﬁc and Sex-Independent Clustering of 
Myocardial Gene Expression Patterns in Human Aortic 
Valvular Disease
Daniel Catanzaro, Jeffrey S. Borer, Fangmin Yu, Ada R. Ene, Clare A. Hochreiter, 
Edmund M. Herrold, Phyllis G. Supino, John N. Carter, Jason Lazar, Arash Salemi, 
Leonard Girardi, O. Wayne Isom, Weill Cornell medical College, New York, NY, SUNY 
Downstate, Brooklyn, NY
Background: Aortic regurgitation (AR) and aortic stenosis (AS) cause cardiac 
hypertrophy characterized by changes in myocyte and extracellular matrix (ECM) biology. 
Experimental models of pressure and volume overload demonstrated changes in a few 
speciﬁc ECM proteins. However, pathophysiological differences between AR and AS 
hearts probably involve many genes.
Method: To determine differences in AR vs AS gene expression patterns Tru-cut biopsies 
were obtained at the thickest portion of the LV free wall from pts undergoing aortic valve 
replacement for isolated, pure AS (4M, 5F) or isolated, pure AR (4M ,3F), and from “control” 
pts with coronary artery disease (CAD) but no infarction undergoing elective bypass grafting 
(4M). Labeled cRNA was used to probe Affymetrix microarrays (Human Genome U133 
Plus 2.0). Data were analyzed using dCHIP and Ingenuity Pathways Analysis.
Results: Comparison of RNA expression (AS vs AR, AS vs CAD, AR vs CAD) revealed 
relative expression excess (p1.2-fold, 557 > 1.5-fold and 112 >2-fold. Gender differences 
also were seen (319 genes >1.2 fold, 158 >1.5-fold, 58 >2-fold). However, most 
differences between AR and AS shared similar magnitude and direction for both genders. 
Associations were found between cardiac dimensions (LVIDd) and genes involved in 
extracellular matrix remodeling (MMP9 r=0.-41, p<0.05 and TIMP4 r=0.-49, p,0.05). 
Pathways analysis revealed highly signiﬁcant gene expression clusters for cell signaling, 
nervous system, development, and lipid metabolism
Conclusion: Signiﬁcant associations between LVIDd and expression of genes involved 
in ECM matrix remodeling suggests that, as in experimental AR/AS, wall stress is directly 
transduced to pathophysiological gene expression. Clustering of gene expression 
patterns suggests the involvement of speciﬁc pathways, whose further elucidation may 
reveal important therapeutic targets.
9:30 a.m.
1034-224 Increased Inﬂammation and Neovascularization in 
Calciﬁc Aortic Stenosis From Patients With End Stage 
Renal Disease
Pedro R. Moreno, Elias A. Zias, Luis Astudillo, K-Raman Purushothaman, Meerarani 
Purushothaman, Patrick A. Lento, John T. Fallon, David Adams, Valentin Fuster, Mount 
Sinai School of Medicine, New York, NY
Background: The mechanisms underlying rapid progression of calciﬁc aortic stenosis 
(AS) in patients with end-stage renal disease (ESRD) on dialysis may involve a more 
aggressive inﬂammatory process, with increased macrophage/T cell, and neovessel 
content when compared to severe aortic stenosis with normal renal function.
Methods: Immunohistochemistry for macrophage/T cell inﬁltration (CD-68+CD-3) and 
neovessel content (CD-34) was performed on 22 calciﬁc AS tissue obtained at the time 
of aortic valve replacement. Patients with ESRD-dialysis (n=9) had lower ejection fraction 
(47 ± 9 versus 57 ± 6; P<0.05), and lower hemoglobin levels (9.5 ± 1 versus 11.3 ± 1.5; 
P<0.05) when compared to patients with normal renal function (n=13). Other variables 
including age, risk factors, incidence of coronary artery disease, aortic valve area, and 
aortic gradient were similar in both groups.
Results: Macrophage/T cell content was increased in ESRD severe AS patients when 
compared to non-ESRD severe AS patients (45 ± 10 versus 30 ± 24; P<0.05). Neovessel 
content was also increased in ESRD severe AS when compared to non-ESRD severe AS 
(33 ± 9 versus 25 ± 5; P<0.05).
Conclusions: The pathogenesis of severe aortic stenosis in patients with ESRD involves a 
more aggressive inﬂammatory and anti-angiogenic proceses, with increased macrophage/T 
cell, and neovessel content. These data provide the basis to consider aggressive anti-
angiogenic therapy to delay progression of calciﬁc AS in dialysis patients.
9:30 a.m.
1034-225 The Relation Between Mitral Annular Calciﬁcation, Lipid 
Proﬁle and C-Reactive Protein Level in the Elderly: The 
Cardiovascular Health Study
Eddy Barasch, John S. Gottdiener MD, Emily K. Marino Larsen, MSc, Paulo H.M. 
Chaves, MD, PhD, Anne B. Newman MD, St. Francis Hospital/SUNY at Stony Brook, 
Roslyn, NY, The University of Maryland Medical Systems, Baltimore, MD
Background: Mitral annular calciﬁcation (MAC) has a prevalence >35% in the elderly and 
is associated with increased cardiovascular morbidity and mortality. Both dyslipidemia and 
inﬂammation are associated with advanced atherosclerosis. We sought to determine the 
association between MAC with serum level of cholesterol, its subfractions, triglycerides 
and C- reactive protein (CRP) in a group of free living community-dwelling elderly 
individuals.
Methods: 2-D echocardiography (echo) was used to determine the presence of MAC, in 
3929 participants (ppts) (mean age 76 ± 5 yrs, 60% women ) in the Cardiovascular Health 
Study, a prospective community based study of risk factors for cardiovascular disease in 
individuals =/> 65 years old. Echo was performed according to a standard protocol at 4 
geographically separate sites, and blindly read at a central lab. MAC was present in 1640 
ppts (42%). This group was compared with 2289 ppts without MAC. ANOVA was used 
adjusted for age, gender and race to determine the signiﬁcant difference between those 
ppts with and without MAC. 
Results: see table below. 
Variable MAC
Yes
N=1640
No
N=2289
Mean
(SD)
Mean
(SD) p-value*
Total
Cholesterol
(mg/dL)
212
(39)
208
(36) 0.001
LDL-C
(mg/dL)
130
(33)
126
(33) <0.001
HDL-C
(mg/dL)
53
(14)
54
(15) 0.01
Triglycerides
(mg/dL)
147
(90)
143
(83) 0.12
CRP
(mg/L)
3.4
(5.8)
3.1
(5.3) 0.02
* ANOVA adjusted for age, gender and race
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1. Participants with MAC have a worse lipid and inﬂammatory proﬁle than those without 
MAC. 2. Normal serum levels of CRP in the elderly are more than 3-fold higher than those 
reported in the general population. 3. MAC should not be considered only a degenerative 
disease of the mitral valve but a marker of active atherogenesis.
9:30 a.m.
1034-226 N-terminal Pro B-type Natriuretic Peptide Predicts the 
Need for Valve Replacement in Asymptomatic Severe 
Aortic Stenosis
Jutta Bergler-Klein, Ursula Klaar, Raphael Rosenhek, Harald Gabriel, Thomas Binder, 
Helmut Baumgartner, Dept. of Cardiology, Med. Univ. of Vienna, Vienna, Austria, 
Munster University, Munster, Germany
Background: We have recently shown that B-type natriuretic peptide (BNP) and its pro-
form NT-proBNP are elevated in symptomatic aortic stenosis (AS) and predict surgical 
outcome. More importantly, BNP predicted events in asymptomatic pts. The clinical 
usefulness of BNP measurements in AS, however, remains, controversial. Therefore, we 
studied a large group of asymptomatic pts with severe AS to further evaluate the potential 
of BNP for timing of surgery in asymptomatic AS.
Methods: In 99 pts with severe asymptomatic AS (age 63±18 yrs, female 44, mean 
gradient MG 64±19 mmHg, valve area AVA 0.67±0.15 cm²) plasma NT-proBNP 
measurement, clinical and echocardiographic evaluation were performed and repeated 
every 6 months as long as pts remained asymptomatic. Aortic valve replacement (AVR) 
was performed when symptoms or LV dysfunction developed. The predictive value of 
NT-proBNP levels and echocardiographic variables for symptom development within the 
following 6 months was analyzed.
Results: A total of 189 NT-proBNP measurements were available for analysis (median 
NT-proBNP 303, interquartile range 151 to 688 pg/ml). When pts developed symptoms 
within the following 6 months (n=24) NT-proBNP levels at the previous visit were 
signiﬁcantly higher than when remaining asymptomatic (n=135): median NT-proBNP 825 
(487 to 1459) pg/ml vs 240 (120 to 512); p<0.0001). Pts developing symptoms within 
the following 6 months also had smaller AVA (0.58±0.15 cm² vs 0.69±0.14, p<0.001) 
and higher MG (80±26 vs 62±17 mmHg, p<0.001) at their previous visit. NT-proBNP 
was signiﬁcantly related to AVA (r=-0.21, p=0.02) and systolic pulmonary artery pressure 
(r=0.38, p<0.001). In 17 pts with speckle tracking echocardiography available, longitudinal 
peak systolic LV strain was signiﬁcantly related to NT-proBNP levels (r=-0.64, p<0.001).
Conclusion: In pts with asymptomatic AS, plasma levels of NT-proBNP are signiﬁcantly 
higher when symptoms develop within the following 6 months than when remaining 
asymptomatic. Natriuretic peptides are easy to assess and may help to deﬁne the optimal 
time for surgical intervention.
9:30 a.m.
1034-227 Atorvastatin Attenuates Severe Myxomatous Mitral 
Regurgitation via Sox9 Regulation of Chondrocyte 
Formation
Nalini Marie Rajamannan, Shahbudin H. Rahimtoola, Northwestern University, Chicago, 
IL, USC, Los Angeles, CA
Background: Myxomatous mitral valve regurgitation is a common cause for mitral 
valve repair in United States and Europe. However, the cellular mechanisms causing 
the myxomatous change are not well known. We hypothesize this phenotype is 
develops secondary to chrondrocytic differentiation via a genetic reprogramming of the 
myoﬁbroblast cell within within the valve leaﬂet causing cartilage to form along the surface 
of the mitral valve.
Methods: Forty eight Watanabe Rabbits weighing 2.5-3.0 kg were assigned to one of 
three groups: a control diet (N=16), 1.0% cholesterol-fed diet (N=16), or cholesterol-
fed and atorvastatin diet (N=16) for six months. Cholesterol-fed animals received a diet 
supplemented with 0.25% cholesterol (wt/wt), and the cholesterol-fed and atorvastatin 
group was given atorvastatin at 2.5 mg/kg/day. All the rabbits underwent TEE using the 
Accunav probe. The mitral valves were harvested and studied. Immunohistochemistry 
was performed with Masson Trichrome, A-actin smooth muscle, proliferating cell nuclear 
antigen (PCNA) and macrophage (RAM11). Bone matrix expression was determined by 
staining for osteopontin (OP), osteocalcin (OC). Alkaline phosphatase, Sox9 and Cbfa1 
gene expression by semiquantitative RTPCR. A 4-point grading system was used to 
visually describe the staining on each of the slides (0=no staining, 4=high staining).
Results: Mitral regurgitation, Macrophage, A-actin, osteopontin and PCNA were 
increased (>3 Fold, p<0.05) the mitral valves from the cholesterol treated rabbits. 
Alkaline phosphatase was unchanged in the control versus cholesterol treatment groups. 
Atorvastatin decreased the amount of mitral regurgitation, atherosclerotic proliferative 
changes, Sox9 and alkaline phosphatase expression in the cholesterol treated 
valves(p<0.05). Osteogenic transcription factor expression was mediated via Sox9 and 
not Cbfa1.
Conclusion: Experimental hypercholesterolemia induces Sox9 mediated proliferation, 
osteopontin and chondrocyte expression in the mitral valve conﬁrming a chrondrocyte 
phenotype in the valve, that may potentially be modiﬁed with the use of a lipid-lowering 
agent.
ACC.POSTER CONTRIBUTIONS
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1043-209 Characterization and Outcomes of Radiation-Induced 
Severe Aortic Stenosis
Sachin S. Goel, Akin Cam, E Murat Tuzcu, Samir R. Kapadia, Cleveland Clinic, 
Cleveland, OH
Background: Survivors of chest radiation often present decades later with severe aortic 
stenosis (AS).
Aim: To compare outcomes of patients with severe symptomatic radiation induced AS 
(RAS) with matched non radiation calciﬁc aortic stenosis (CAS) patients.
Methods: A total of 20 consecutive patients > 60 years with severe (AVA a 1 cm2) RAS 
identiﬁed from 810 patients with severe AS undergoing coronary angiograms between 
2004 and 2007 from the hospital database were compared with 20 surgical risk matched 
controls with severe CAS.
Results: STS score was similar in the 2 groups (table). Severe mitral annular calciﬁcation 
was more common in RAS group. Similar proportion of patients underwent surgical 
aortic valve replacement (AVR) in each group (75% vs. 80%, p=1.0). Overall mortality 
was not signiﬁcantly different between the 2 groups (35% vs. 20%, p=0.48). Incidence 
of signiﬁcant post operative complications and average length of post operative hospital 
stay were not different between the 2 groups. No patient in the RAS group needed 
postoperative tracheostomy. Post operative survival was similar between the 2 groups 
(log rank p=0.4, wilcoxon p=0.9). Patients who did not undergo AVR had a high mortality 
(60%, 25% respectively in the 2 groups) at an average follow up of 2 years.
Conclusion: Signiﬁcant no. of patients with RAS can undergo successful AVR. Their 
outcomes were comparable to a matched control cohort in our study. Patients who did not 
undergo surgery had very high mortality. 
Characteristics Radiation induced severe AS (RAS) (n=20)
Severe calciﬁc 
AS (CAS)
(n =20)
P
value
Age
CAD >30% obstruction (%)
Male (%)
Hypertension (%)
Diabetes (%)
Hyperlipidemia (%)
Smoking history(%)
Statin use(%)
Peripheral arterial disease (%)
Creatinine (mg/dL)
72 ± 9
75
25
60
15
70
37
40
10
0.9 ± 0.2
73 ± 5
90
65
75
10
75
35
60
35
1.0 ± 0.3
0.65
0.40
0.02
1.0
1.0
1.0
1.0
0.34
0.13
0.16
Total Cholesterol (mg/dL)
LDL (mg/dL)
HDL(mg/dL)
Triglycerides (mg/dL)
184 ± 54
104 ± 45
55 ± 14
121 ± 59
164 ± 40
94 ± 32
50 ± 15
102 ± 49
0.19
0.38
0.25
0.27
Aortic valve area (cm2)
Peak gradient (mm of Hg)
Mean gradient (mm of Hg)
Aortic insufﬁciency
Ejection fraction (%)
Mitral regurgitation
Right ventricular systolic 
pressure (mm Hg)
Moderate or severe Mitral 
annular calciﬁcation (%)
0.7 ± 0.2
65 ± 20
37 ± 14
1.5 ± 1.1
57 ± 11
1.3 ± 1.0
48 ± 20
65
0.8 ± 0.2
70 ± 22
41 ± 14
1.3 ± 0.6
51 ± 13
1.0 ± 0.9
40 ± 10
20
0.5
0.53
0.39
0.5
0.16
0.32
0.22
0.01
STS Score 4.4 ± 3.0 5.4 ± 5.4 0.46
AVR % 75 80 1.0
Death % 35 20 0.48
Post AVR days to discharge 8.6 ± 4.8 12.8 ± 11.3 0.2
Post AVR complications
Tracheostomy (n)
Sternal wound infection (n)
0
1
2
0
-
-
3:30 p.m.
1043-210 High Glucose Induces Osteoblastic Gene Expression in 
Aortic Valve Interstitial Cells
Kemal Akat, Julia Hardt, Martin Borggrefe, Jens J. Kaden, First Department of Medicine 
(Cardiology), Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany
Background: The osteoblastic transdifferentiation of valve interstitial cells (VICs) is an 
important step in the pathogenesis of calciﬁc aortic valve stenosis (CAVS) but remains 
incompletely understood. The metabolic syndrome is associated with a faster disease 
progression of native valves and with a faster degeneration of bioprosthetic valves. 
Cholesterol is established to increase osteogenic gene expression in vitro but clinical 
trials failed to show a clear beneﬁt of statin treatment. We therefore investigated the role 
of glucose on the osteoblastic transdifferentiation of VICs.
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added to the routine warfarin therapy in Group 1 pts who were considered to have a 
higher risk for thromboembolism. All pts were evaluated monthly to maintain an optimal 
INR (International Normalized Ratio) level of >2,5 during their follow-up period (mean: 5.2 
years ) and TEE was performed every year.
Results: Total lysis of the thrombus was detected in 44.4% (n=67) of pts and this was 
higher among the pts in group 1 than in group 2 [58.1% (n=25) versus 38.9% (n=42), 
p<0.05]. There was a partial decrease in the thrombus dimentions in 29.1% (n=44) and 
no change in 26.5% (n=40) of all pts. In group 1, 1 pt had hemorrhagic stroke, 1 pt 
experienced TIA, 4 pts had upper gastrointestinal bleeding and 7 pts had minor bleeding 
episodes. In group 2, 3 pts experienced TIA, 1 pt had ischemic stroke and 5 pts had minor 
bleeding complications. Death was not observed in both groups.
Conclusion: Although, adding 300 mg ASA to warfarin in high-risk pts may increase the 
tendency of hemorrhagic complications, it may also has an additive beneﬁcial effect by 
increasing the probability of total thrombolysis and make an additional decrease in the 
number of thromboembolic complications.
3:30 p.m.
1043-213 Effect of Bisphosphonates on Progression of 
Degenerative Aortic Stenosis
Antony Leslie Innasimuthu, William E. Katz, University of Pittsburgh Medical Center, 
Pittsburgh, PA
Background: Degenerative aortic stenosis (AS) is thought to be due to vascular 
calciﬁcation. Bisphosphonates (Bph) appear to regulate mineralization in both bone and 
vasculature. We studied effect of Bph on the progression of degenerative AS.
Methods: A retrospective study was performed on patients >70 years, who had 2 
transthoracic echocardiograms (TTE), with the 2nd study within 2 years of the ﬁrst and 
an initial aortic valve area (AVA) of 0.6-2.0 cm2. Patients were excluded if they had an 
ejection fraction <40%,bicuspid aortic valve, >2+ aortic regurgitation, mitral valve disease 
or end-stage renal disease. The cohort was divided depending on the use of Bph during 
the time between the TTE. AVA, peak and mean aortic valve gradient (AVG), and their 
change between the studies were calculated. The data was analyzed using Mann-Whitney 
non-parametric test (p<0.05 was considered signiﬁcant).
Results: Of 4270 patients with AS screened, 76 patients (Male: 42 (55%); Average age: 
80 years) ﬁt study criteria with 8 in the Bph group and 68 in the non-Bph group. The 
period between the 2 TTE was 23±5 months in both the groups. AVA in the non-Bph group 
worsened by 0.2 cm2 and in the Bph group it improved by 0.1 cm2 (p=0.001 vs Non-Bph). 
The changes in peak and mean AVG between groups and compared to baseline were 
not signiﬁcant.
Conclusions: Bph show promise in slowing the progression of degenerative AS. A 
prospective, randomized, clinical trial with a larger number of patients is required to 
conﬁrm these preliminary ﬁndings.
Average AVA, Peak AVG and Mean AVG and EF in both groups (* 
p<0.05 vs baseline)
Bisphosphonate
(n=8)
Bisphosphonate
(n=8)
Non-
bisphosphonate
(n=68)
Non-
bisphosphonate
(n=68)
1st Study 2nd Study 1st Study 2nd Study
Average AVA 
(cm2) 0.7±0.2 0.8±0.3* 1.2±0.3 1.0±0.3*
Average Peak 
AVG (mm of 
Hg)
34±11 37±15 39±17 45±19
Average Mean 
AVG (mm of 
Hg)
18±8 21±7 24±11 29±13
EF (%) 63±9 65±9 60±7 59±7
3:30 p.m.
1043-214 The Effect of Low Dose Atorvastatin on the Progression 
of Aortic Valve Calciﬁcation
Mark J. Goldman, Marguerite A. Roth, Dipti Gupta, Jing Han, Alan D. Guerci, Nathaniel 
Reichek, St. Francis Hospital, Roslyn, NY, Stony Brook University Medical Center, Stony 
Brook, NY
Background: Statin therapy may slow progression of aortic valve calciﬁcation (AVC) 
and stenosis but results are inconsistent and only subjects with overt aortic stenosis 
have been evaluated. We retrospectively reviewed St. Francis Heart Study data to test 
the hypothesis that statin administration can reduce progression of AVC in subjects with 
elevated coronary calcium score (CAC).
Methods: Subjects with CAC >80th percentile for gender and age were randomized 
to either 20 mg atorvastatin, 1000 U vitamin E and 1 g vitamin C per day or matching 
placebos. We evaluated baseline and exit calcium scans (mean follow-up 4.1±0.8 years) 
in 373 subjects (185 treatment, 188 placebo; 327 male; mean age 61.3±5.8 years), with 
intake CAC q400 Agatston Units. Scans were scored for AVC and adjacent aortic wall 
calciﬁcation (AWC) by a physician blinded to clinical data. Absolute and normalized 
changes and mean change rates for calcium scores and LDL were determined and 
compared using Wilcoxon’s rank sum test.
Results: AVC was seen in 142/373 subjects (38%) at intake [mean (mn) 179±358, 
median (med) 50 (13, 201)] and 190/373 (51%) on exit scans [mn 280±709, med 66 (19, 
274)] (p=0.0004). AWC was seen in 74/373 (20%) at intake [mn 61±84, med 27 (8, 70)] 
and 92/373 (25%) on exit scans [mn 82±108, med 37 (12, 106)] (p=0.11). Both AVC and 
AWC were present on 36/373 (10%) at intake and 57/373 (15%) on exit scans. Treatment 
decreased progression of AVC only in patients with AVC+AWC (p=0.01), and signiﬁcantly 
Methods: Valve interstitial cells from porcine and bovine aortic valves were cultured 
in DMEM containing 5.56 mM glucose, 25 mM glucose or 25 mM glucose/mannitol 
supplemented with 15 % FCS and 50 μg/ml ascorbic acid for up to 10 days. The gene 
expression of alkaline phosphatase (AP), osteocalcin (OC), Runx2, and type I collagen 
(col I) was quantiﬁed by real time PCR. The protein amount of alkaline phospatase was 
measured, and calciﬁcation was measured by densitometry of von Kossa-stained cells.
Results: All genes showed a signiﬁcant increase in gene expression after treatment with 
high glucose (fold change +/-SD): AP 6.02 +/-11.93 (p=0.0008); OC 2.45 +/-0.42 (p=0.022); 
Runx2 4.70 +/-1.37 (p=0.043); col I 16.08 +/-10.33 (p=0.016). The concentration of alkaline 
phosphatase was 5393 pg/ml (SD=103 pg/ml) in cells grown in low glucose and 8898 pg/
ml (SD=1320 pg/ml) in cells grown in high glucose (n=3, p=0.038). Densitometric analysis 
of von Kossa-stained mineralized nodules after incubation for 10 days showed an about 4 
times higher value in cells grown in high glucose media compared with controls (arbitrary 
units +/-SD): 431 +/-111 in high glucose vs. 337 +-95 in low glucose (n=3, p=0.026).
Conclusions: A high glucose concentration induces an osteoblastic transdifferentiation 
in VICs. This is reﬂected by differences in gene expression and phenotype. These results 
contribute to the hypothesis that diabetes might negatively inﬂuence CAVS.
3:30 p.m.
1043-211 Multidirectional Myocardial Strain Analysis in Severe 
Aortic Stenosis Patients: Two-Dimensional Speckle 
Tracking Assessment Before and After Aortic Valve 
Replacement
Victoria Delgado, Rutger R. van Bommel, Frank van der Kley, Arnold CT Ng, Nina 
Ajmone Marsan, Laurens F. Tops, Michel IM Versteegh, Robert J. Klautz, Eduard R. 
Holman, Eernst E. van der Wall, Martin J. Schalij, Jeroen J. Bax, Leiden University 
Medical Center, Leiden, The Netherlands
Background:In severe aortic stenosis (AS) patients, a normal LV ejection fraction (EF) 
is not synonymous of preserved LV mechanics. The aim of the study was to demonstrate 
the presence of abnormal LV strain in patients with severe AS and normal LVEF using 
2-dimensional speckle tracking imaging (2DSTI).
Methods:Multidirectional strain/strain rate of the LV was evaluated by 2DSTI in 100 
patients (66±13 years, 61% men) with severe AS and normal LVEF. After aortic valve 
replacement (AVR), changes in LV myocardial strain were evaluated at short-term 
(<1month, n = 30) and at long-term follow-up (FU) (>3 months, n = 70). The control group 
included 20 aged-matched healthy individuals.
Results: At baseline, severe AS patients showed reduced values of strain/strain rate in 
all the 3 directions (Table). After AVR the aortic valve area signiﬁcantly increased (from 
0.7 ± 0.2 cm2 to 1.6 ± 0.5 cm2, p<0.001) and the maximal valvular pressure gradient 
signiﬁcantly decreased (from 72 ± 21 mmHg to 22 ± 9 mmHg, p<0.001) whereas LVEF 
remained unchanged (Table). Signiﬁcant improvement in multidirectional LV strain was 
observed in patients with long-term FU along with a reduction in LV mass (Table). In 
contrast, patients with short-term FU did not show any improvement in LV strain or 
reduction in LV mass.
Conclusions:In severe AS patients with normal LVEF, 2DSTI demonstrates the presence 
of impaired multidirectional LV strain. At long-term FU after AVR, myocardial strain 
improves signiﬁcantly in all 3 directions.
*pa 0.01 vs. baseline; †p<0.05 vs. baseline; ‡p<0.0001 vs.baseline
Controls(N 
=20) Short-term FU (N=30) Long-term FU (N=70)
Baseline After AVR Baseline After AVR
LVEF (%) 62 ± 8 61 ± 8 60 ± 7 61 ± 11 60 ± 12
LV Mass index (g/m2) 100 ± 18 154 ± 47 144 ± 45 158 ± 50 124 ± 38‡
Radial Strain (%) 38.5 ± 8.1 33.9 ± 16.4 30.2 ± 12.9 32.2 ± 14.2 36.3 ± 13.1†
Radial Strain rate (1/s) 2.2 ± 0.7 1.8 ± 0.9 1.9 ± 0.6 1.7 ± 0.6 2.0 ± 0.7†
Circumferential Strain (%) -19.0 ± 3.2 -15.3 ± 4.4 -15.3 ± 5.6 -15.0 ± 5.1 -18.1 ± 5.5‡
Circumferential Strain rate 
(1/s) -1.3 ± 0.3 -0.8 ± 0.3 -1.1 ± 0.3 * -0.9 ± 0.3 -1.1 ± 0.3‡
Longitudinal Strain (%) -19.9 ± 2.1 -14.6 ± 3.4 -13.6 ± 3.2 -14.6 ± 4.1 -16.3 ± 4.5‡
Longitudinal Strain rate (1/s) -1.1 ± 0.2 -0.7 ± 0.2 -0.8 ± 0.2 * -0.7 ± 0.2 -0.9 ± 0.2‡
3:30 p.m.
1043-212 Long-Term Clinical Follow-up of Patients With Non-
Obstructive Thrombus of Mechanical Heart Valves by 
Serial Transesophageal Echocardiography
Emre Erturk, Mehmet Ali Astarcıoglu, Nilufer Eksi Duran, Yusuf Karavelioglu, Tayyar 
Gokdeniz, Hasan Kaya, Nihal Ozdemir, Mehmet Ozkan, Kosuyolu Heart and Research 
Hospital, Istanbul, Turkey
Objectives: We aimed to investigate the effects of optimal medical therapy on the 
morbidity and the mortality in pts with non-obstructive prosthetic valve thrombosis (NOT) 
and evaluate the beneﬁcial effects of 300 mg acetylsalisilic acid (ASA) added to warfarin 
monotherapy.
Background: Current knowledge about the clinical long term follow-up of pts with NOT 
is lacking.
Method: Our study population was comprised of 151 consecutive pts (male: 54, female: 97, 
mean age: 48.9 years) presented between 1993 and 2008 to our institution and detected 
to have a NOT (mitral: 138, aort:13) during their transesophageal echocardiographic 
(TEE) examination. Patients who had double/triple mechanical heart valves or a previous 
episode of a transient ischemic attack (TIA) / ischemic stroke and the ones who have a 
left atrial size larger than 5.5 cm or a dense spontaneous echo contrast on TEE were 
included in the Group 1 (n=43) and the others in group 2 (n=108). 300 mg ASA was 
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3:30 p.m.
1043-222 The GPIIIa PlA And GPIb Kozak Polymorphisms 
Inﬂuence Staphylococcus Aureus-Induced Platelet 
Aggregation and May Represent Novel Risk Factors for 
Infective Endocarditis
Shruti Daga, James G. Shepherd, J. Garreth S. Callaghan, Rachel K.Y. Hung, David E. 
Newby, J. Ross Fitzgerald, University of Edinburgh, Edinburgh, United Kingdom
Background: S. aureus-platelet interactions are important in the pathogenesis of 
infective endocarditis (IE) and are mediated by platelet FcGRIIa, GPIIb/IIIa and GPIb 
receptors. Polymorphisms of these receptors inﬂuence susceptibility to cardiovascular, 
cerebrovascular and autoimmune diseases but their relevance to the outcome of IE is 
unknown. The aims of the current study were to investigate the role of platelet receptor 
polymorphisms in S. aureus-induced platelet aggregation and the development of IE.
Methods: FcGRIIa H131R, GPIIb/IIIa PlA and the Kozak, VNTR and HPA-2 polymorphisms 
of GPIb were determined in 153 healthy volunteers. Lag time to and maximal percent 
aggregation to S. aureus were determined by platelet aggregometry.
Results: Multivariate analysis identiﬁed reduced lag times to S. aureus-induced platelet 
aggregation in individuals possessing the PlA A1 allele (A1/A1 1.95 ± 0.63 min vs. A1/
A2 2.01 ± 1.04 min vs. A2/A2 3.13 ± 1.82, P=0.012) and in females (1.79 ± 0.55 min vs. 
2.28 ± 0.87 min, P=0.045). Lag times were shorter in PlA homozygous female subjects 
and heterozygous males (P=0.032). There was a trend towards increased percent platelet 
aggregation in subjects homozygous for PlA2 (A1/A1 64 ± 16%, A1/A2 64 ± 14%, A2/
A2 70 ± 17%, P=0.063)
Interestingly, an interactive effect was observed between the PlA and Kozak 
polymorphisms. Reduced susceptibility to S. aureus-induced platelet aggregation was 
observed in individuals possessing A1/A2 T/C or A2/A2 T/T genotypes (P=0.032).
Conclusions: We have shown for the ﬁrst time that gender, the GPIIIa PlA and GPIb 
Kozak polymorphisms in combination affect bacterium-induced platelet aggregation. These 
ﬁndings may have broader implications for the risk stratiﬁcation and treatment of IE.
3:30 p.m.
1043-223 Aortic Valve Resistance-Aortic Valve Area Relation 
Curve Improves Precision of Assessment of Aortic 
Stenosis
Hideaki Kanzaki, Makoto Amaki, Takuya Hasegawa, Takahiro Ohara, Kazuhiko 
Hashimura, Masafumi Kitakaze, National Cardiovascular Center, Osaka, Japan
Background: Some patients with low-gradient aortic stenosis (AS) have a low calculated 
aortic valve area (AVA), because there is not enough forward ﬂow to fully open the 
leaﬂets. For the standardized evaluation, transvalvular ﬂow rate (TVFR) of 250 mL/sec 
was reported to be needed. Our objective was to establish a method to improve the 
precision of severity assessment of organic AS.
Methods: In 133 patients (LVEF 59±15%), AVA and aortic valve resistance (AVR) 
were obtained with echocardiography. AVA was determined according to the continuity 
equation and AVR was calculated using the following formula: 1.333×mean pressure 
gradient/TVFR, where TVFR=stroke volume/ejection time.
Results: Forty patients who had TVFR>250 mL/sec showed a strong correlation between 
their AVR and AVA (r=0.977, solid circles in Figure). In 18 of 93 patients with low TVFR 
(open circles), dobutamine stress echocardiography was performed. TVFR was increased 
from 204±32 to 284±64 mL/sec (P<0.001) and AVA was changed from 0.82±0.17 to 
0.97±0.23 cm2 (P=0.031) by up to 20 μg/kg/min of dobutamine infusion, whereas AVR 
was relatively constant in this range (from 206±71 to 211±80 dynes.sec.cm-5, P=NS). The 
AVA estimated from the resting AVR using the AVR-AVA relation curve (0.96±0.19 cm2)
was corresponding to the AVA revealed by dobutamine stress (r=0.733, P<0.001).
Conclusions: A close relationship existed between AVR and AVA. Proper AVA may be 
estimated from resting AVR, being helpful to distinguish patients with pseudo-severe AS.
decreased progression of AWC only in those with AVC+AWC (p=0.006).
Conclusions: Treatment reduced progression of aortic valve calciﬁcation only in patients 
with wall calcium and reduced progression of aortic wall calciﬁcation only in patients 
with valve calcium, suggesting that the behavior of calciﬁcation may differ in patients 
with combined AVC and AWC as opposed to either alone. Patients with combined AVC 
and AWC may be more responsive to prophylactic treatment and should be a focus in 
future trials.
3:30 p.m.
1043-215 Quality of Life and NYHA Class After Percutaneous 
Aortic Valve Replacement for Aortic Stenosis
Gian Paolo Ussia, Massimiliano Mulè, Marco Barbanti, Marilena Scarabelli, Valeria 
Cammalleri, Sebastiano Immè, Davide Capodanno, Corrado Tamburino, Catania, Italy
Background: Percutaneous aortic valve replacement (PAVR) for severe aortic stenosis 
is a promising therapeutic technique, alternative to surgery, for patients at high risk for 
surgical intervention. Preliminary results have been evaluated as event-free survival, but 
no data are available about functional status and Quality of Life (QoL). The aim of this 
study is to assess the NYHA class and QoL scores after PAVR with the 18-Fr CoreValve™ 
prosthesis.
Methods: From April 2007 until August 2008, 57 consecutive patients with aortic valve 
stenosis were evaluated for PAVR. Of these, thirty patients with successfully prosthesis 
implantation had more than 5 months follow-up. QoL assessment was realized with 
the SF-12v2® Health-Survey, a simple questionnaire designed for self-administration 
that provides easily interpretable scales for physical (PCS) and mental (MCS) health, 
considering 8 concepts commonly represented in health surveys: physical functioning, 
role functioning physical, bodily pain, general health, vitality, social functioning, role 
functioning emotional, and mental health. The questionnaire was administered before 
and ﬁve months after PAVR.
Results: All 30 patients had a marked upgrading in hemodynamic and echocardiographic 
parameters (peak-to-peak gradient from 64±23 to 2±0,4; p<0,001. Aortic Valve Area 
Index from 0,3±0,1 to 0,9±0,3; p<0,001), with an improvement in NYHA class at discharge 
and after 5 months. Mean preoperative SF-12v2® scores showed a severe impairment 
of perceived quality of life compared to general Italian population >75 years, both for 
physical (baseline-PCS 28,5) and mental scores (baseline-MCS 37,8). After 5 months a 
striking improvement in both scores (PCS 41,3-MCS 48,3; p<0,001) were observed.
Conclusions: Our preliminary results seem to show a marked improvement in functional 
status and physical and mental health in patients underwent PAVR.
3:30 p.m.
1043-221 Elevation in Brain Natriuretic Peptide Predicts 
Outcomes in Infective Endocarditis
Angela Shiue, Jonathan Purcell, Amy Stancoven, Kristi Pinkston, Mahesh Patel, Andrew 
Wang, Amit Khera, James A. De Lemos, Gail E. Peterson, UT Southwestern, Dallas, TX
Background: Elevated brain natriuretic peptide (BNP) is a marker of poor outcomes in 
heart failure, acute coronary syndromes and sepsis. We have previously shown elevated 
(k) troponin (cTnI) predicts outcomes in infective endocarditis (IE). We hypothesized 
patients (pts) with IE and k BNP would be at increased risk for morbidity and mortality.
Methods: Patients were enrolled as part of the International Collaboration on Endocarditis 
Prospective Cohort Study. Data from 103 consecutively enrolled pts from a single center 
were evaluated. Of 103 pts enrolled, 44 had BNP drawn and 64 had cTnI drawn for clinical 
indications. The association between k BNP (q 400 pg/mL) and k cTnI (q 0.1 ng/mL) with 
hospital mortality, intracardiac abscess, and CNS events was determined.
Results: Of pts with BNP or cTnI drawn, 30 (68.2%) had k BNP and 44 (68.8%) had k
cTnI. Median BNP was higher among pts with the composite outcome (1498 vs 391 pg/
mL; p=0.03) and among those who died (2150 vs 625 pg/mL; p=0.04). Elevated BNP 
was associated with the composite of death, abscess, and CNS events (ﬁgure; p=0.02). 
Patients with both k BNP and cTnI had signiﬁcantly worse composite outcome (70.8%) 
than pts with only BNP or cTnI k (37.5%) or neither k (0.0%) (p-trend< 0.01).
Conclusion: A large proportion of pts with IE have k BNP. Our data demonstrate a 
signiﬁcant association between BNP elevation (alone and combined with cTnI) with the 
composite endpoint in pts with IE. Further prospective evaluation of the role of BNP in 
IE is warranted. 
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1043-226 Nineteen-Year Clinical and Echocardiographic Follow-
Up Results of Mitral Balloon Valvuloplasty in 547 
Consecutive Patients and Predictors of Long-Term 
Outcome
Mohamed Eid Fawzy, Hani Al Sergani, Bahaa Fadel, Mohammad Kandeel, Shabir Shah, 
Abdulmoniem ElDali, Charles Canver, King Faisal Specialist Hospital, Riyadh, Saudi 
Arabia
Background: Long-term echocardiographic follow-up studies of mitral balloon 
valvuloplasty (MBV) are scarce. The aim of this study was to assess the long term 
results (up to 19 years) of MBV in 547 consecutive patients and to identify predictors of 
restenosis and event-free survival.
Methods: The immediate and long term clinical and echocardiographic results of 547 
consecutive patients, (mean age 31.5 ± 11 years, who underwent successful MBV for 
severe mitral stenosis (MS) and were followed up for mean 8.8 ± 5years (range 1 - 19 
years) after MBV are reported. Predictors of restenosis and event free survival were 
estimated using multivariable Cox regression analysis.
Results: Immediately after MBV, the mitral valve area (MVA) increased from 0.92 ± 
0.17 cm2 to 1.95 ± 0.29 cm2 (P < 0.0001. Restenosis occurred in 169 (31%), and was 
less frequent 20% in patients with mitral echo score (MES a 8). Actuarial freedom 
from restenosis at 10, 15, 19 years were (77 ± 2%, 46 ± 3%, 18 ± 5%) respectively, 
and were signiﬁcantly higher in patients with (MES a 8) (88 ± 2%, 66 ± 4%, 30 ± 7%) 
respectively (P < 0.001). Event-free survival (death, redo MBV, mitral valve replacement, 
NYHA Functional Class III or IV) at 10, 15, 19 years were 88 ± 2%, 53 ± 4%, 20 ± 7% 
respectively, and were signiﬁcantly higher for patients with (MES a 8) 92 ± 1%, 67 ± 4%, 
38 ± 8% respectively (P < 0.001). Multivariable Cox regression analysis identiﬁed MES> 
8 (P < 0.0001) immediate MVA < 2.0 (P = 0.017) and pulmonary hypertension (P = 0.008) 
as predictors of restenosis, and MES > 8 (P < 0.0001) as predictor of combined events.
Conclusions: MBV provides excellent long-term results up to 19 years for selected 
patients with MS. The long-term outcome of this procedure can be predicted from baseline 
clinical and echocardiographic characteristics of the mitral valve.
3:30 p.m.
1043-227 oxLDL Induces the Expression of MCP-1 in Aortic Valve 
Myoﬁbroblasts via Activation of NF-kappa B - Inhibitory 
Effects of Recombinant Apo AI-Milano
Giovanni Cimmino, Walter S. Speidl, Borja Ibanez, Jose Manuel Garcia Ruiz, Valentin 
Fuster, Juan J. Badimon, Atherothrombosis Reserach Unit, Cardiovascular Institute, 
Mount Sinai Hospital, New York, NY
Background: Aortic valve stenosis (AS) is characterized by atherosclerosis-like lesions 
on the valve leaﬂets. Inﬁltration of monocytes within the leaﬂets may be a key step in the 
initiation and progression of AS. Hyperlipemia has been associated with progression of 
AS and we have recently shown that recombinant Apo AI-Milano (Apo AI-M) treatment 
rapidly reduces AS in a hyperlipemic rabbit model. Therefore we wanted to investigate 
whether oxLDL may increase the expression of the highly chemotactic protein monocyte 
chemoattractant protein-1 (MCP-1) in aortic valve myoﬁbroblasts and whether this effect 
could be inhibited by recombinant Apo AI-M.
Methods: Aortic valve myoﬁbroblasts were isolated from pig aortic valves (PAVMF). The 
time course and dose response of MCP-1 mRNA expression and MCP-1 protein release 
into medium following oxLDL stimulation were assessed using quantitative Real time 
PCR and ELISA, respectively. Activation of the nuclear factor NF-kappa B was assessed 
by an ELISA-based nuclear shift assay.
Results: oxLDL treatment of PAVMF increased the expression of MCP-1 mRNA in a 
time- and dose- dependent manner up to 1.97+/-0.24-fold at 12 hours compared to non-
stimulated cells (p<0.05). This was associated with a dose-dependent increase of MCP-1 
protein with peak levels at 24 hours (control vs. oxLDL 25 μg/mL: 164+/-25 vs. 664+/-77 
pg/ml; p<0.01). Four hours pre-treatment with Apo AI-M (140μg/mL) markedly suppressed 
these stimulating effects of oxLDL (338+/-38pg/ml, p=0.017). oxLDL up-regulated MCP-1 
mRNA gene expression via NF-kappa B p50 activation (p<0.01). This was signiﬁcantly 
suppressed by pre-incubation with Apo AI-M.
Conclusions: Our results, taken together with previous clinical and preclinical 
observations, suggest that hyperlipemia may induce inﬁltration of monocytes within aortic 
valve leaﬂets and therapeutic interventions, involving active removal of cholesterol, like 
Apo AI-M, may be effective for treatment of AS.
3:30 p.m.
1043-224 Impact of Severity of Aortic Valve Stenosis on Effect of 
Intensive Lipid-Lowering Therapy: The SEAS Study
Eva Gerdts, Anne B. Rossebø, Terje R. Pedersen, Kurt Boman, John B. Chambers, 
Kenneth Egstrup, Christa Gohlke-Bärwolf, Ingar M. Holme, Antero Kesäniemi, Christoph 
A. Nienaber, Simon Ray, Terje Skjærpe, Kristian Wachtell, Ronnie Willenheimer, 
University of Bergen, Bergen, Norway, University of Lund, Malmø, Sweden
Background: We recently reported from the Simvastatin Ezetimibe in Aortic Stenosis 
(SEAS) study that 4.3 years combined treatment with simvastatin 40 mg and ezetimibe 
10 mg (SE) compared to placebo did not reduce rates of combined major cardiovascular 
events (MCE) or aortic valve related events (AVE), but signiﬁcantly reduced ischemic 
cardiovascular (ICE) events in patients with asymptomatic aortic stenosis (AS). However, 
the impact of severity of AS on treatment effect remains unknown.
Methods: We used baseline and outcome data in 1763 patients (mean age 68 years, 39 
% women) randomized in the SEAS study. The study population was divided into tertiles 
of baseline peak aortic jet velocity (Tertile 1: <2.8m/sec; Tertile 2: 2.8-3.3m/sec, Tertile 3: 
>3.3m/sec). Treatment effect on rate of clinical events was compared within tertile groups 
and interaction tested in Cox regression analysis.
Results: The rate of MCE, AVE and ICE increased with increasing baseline severity of AS 
(Table). The treatment difference tended to be larger in the lower tertile, but signiﬁcantly only 
for ICE. Cox regression demonstrated signiﬁcant interaction between baseline peak aortic 
jet velocity and SE treatment for MCE and ICE (both p<0.05), but not for AVE (p=0.10).
Conclusions: In spite of a strong relation between baseline severity of AS and rate 
of clinical events, the SEAS study results do not conﬁrm any beneﬁcial effect of lipid 
lowering treatment on AVE, even in initial mild AS.
Table. Rate of clinical events by treatment group
Tertile 1 Tertile 2 Tertile 3
MCE AVE ICE MCE AVE ICE MCE AVE ICE
Treatment 15.2 12.8 8.8 29.4 27.0 11.9 58.1 55.4 25.5
Placebo 19.8 15.5 15.8 33.7 30.6 18.6 56.7 55.0 23.8
HR
95% CI
0.76
0.51-
1.12
0.84
0.54-
1.29
0.54
0.33-
0.88
0.86
0.64-
1.15
0.87
0.64-
1.18
0.63
0.41-
0.97
1.07
0.87-
1.32
1.04
0.84-
1.29
1.10
0.79-
1.51
P 0.083 0.182 0.004 0.429 0.421 0.033 0.972 0.838 0.797
HR= Hazard Ratio; CI=Conﬁdence Intervals; P=statistical signiﬁcance
3:30 p.m.
1043-225 C-reactive Protein in Mild to Moderate Aortic Stenosis: 
Findings of the ASTRONOMER Study
Kwan-Leung Chan, James Tam, Randall Sochowski, Jean Dumesnil, Peter 
Giannoccaro, John Jue, Shekhar Pandey, Cam Joyner, Koon Teo, University of Ottawa 
Heart Institute, Ottawa, ON, Canada
Background: Aortic stenosis (AS) is an active process in which inﬂammation appears 
to have an active role. High-sensitive C-reactive protein (CRP) has been shown to be a 
biomarker of inﬂammation and have incremental prognostic value beyond lipid levels in 
patients with atherosclerosis. The present study is to assess the relationship of CRP with 
AS severity and clinical characteristics in patients with mild to moderate AS.
Method: The ASTRONOMER study is a randomized trial assessing the effect of 
cholesterol lowering on AS progression in patients with mild to moderate AS. Patients 
with any indication for cholesterol lowering were excluded from the study. Patients were 
divided into tertiles based on CRP levels. Chi-square tests and one-way ANOVA models 
were used to compare tertile groups for clinical and biochemical measures.
Results: The median CRP for the whole group was 1.78 mg/l (IQR: 0.92, 3.73) with 78 
patients (30.6% 95%CI: 25.3, 36.5) having values > 3 mg/l. 
CRP lower tertile
n = 63
CRP middle tertile
n = 128
CRP upper tertile
n = 64 p-value
Age (years) 52.92 (13.05) 59.56 (12.97) 58.55 (13.32) 0.004
Men (%) 41 (65.1) 85 (66.4) 31 (48.4) 0.044
Smoker 22 (34.9) 62 (48.4) 38 (59.4) 0.022
BMI 25.74 (3.26) 28.34 (5.09) 30.4 (7.84) <0.001*
Systolic BP mmHg 123.44 (14.65) 128.28 (15.65) 126.41 (15.97) 0.129
Diastolic BP mmHg 74.17 (8.64) 76.78 (9.94) 74.97 (9.83) 0.169
Total cholesterol 
mmol/l 5.23 (0.73) 5.35 (0.72) 5.26 (0.81) 0.483
HDL-C mmol/l 1.67 (0.48) 1.52 (0.41) 1.55 (0.41) 0.073
LDL-C mmol/l 3.06 (0.68) 3.24 (0.62) 3.09 (0.66) 0.106
Triglycerides mmol/l 1.09 (0.51) 1.27 (0.44) 1.35 (0.55) 0.008
Calcium mmol/l 2.36 (0.09) 2.37 (0.09) 2.34 (0.10) 0.216
Phosphate mmol/l 1.08 (0.16) 1.06 (0.16) 1.06 (0.15) 0.741
Creatinine mmol/l 79.32 (15.30) 82.22 (15.92) 78.78 (15.63) 0.269
ACE-I use (%) 7 (11.1) 12 (9.4) 5 (7.8) 0.816
BAV (%) 41 (65.1) 53 (41.4) 30 (46.9) 0.045
AS maximum gradient 38.18 (10.67) 41.94 (11.23) 40.99 (10.66) 0.084
AS mean gradient 20.96 (6.88) 23.46 (7.78) 22.42 (7.76) 0.101
* signiﬁcant after a Bonferroni correction for multiple testing
Conclusion: High CRP levels (> 3mg/l) are common in patients with mild to moderate 
AS. In these patients, CRP is positively associated with BMI but does not appear to be 
signiﬁcantly associated with AS severity and lipid levels. Whether CRP may be useful in 
predicting AS progression will be assessed in the ongoing ASTRONOMER study.
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1052-211 Impact of Left Atrial Remodeling After Successful Mitral 
Ballon Valvuloplasty on Long-Term Clinical Outcome
Kyong-Hee Kim, Sung-A Chang, Hyung-Kwan Kim, Dae-Won Sohn, Hyuk-Jae Chang, 
Yong-Jin Kim, Cardiovascular Center, Seoul National University Hospital, Seoul, South 
Korea
Background: Increment of left atrial (LA) volume is an independent prognosticator 
in various cardiac diseases. However, the changes of LA volume after successful 
percutaneous mitral valvuloplasty (PMV) and its impact on clinical outcome have not been 
fully elucidated. We assessed the impact of LA volume changes on long-term outcome 
after successful PMV. Methods: A retrospective analysis was performed in 319 patients 
[256 women, age: 39±11 years] with mitral stenosis who had undergone successful PMV 
over a 15 year period. Echocardiogram was obtained before and every one year after PMV. 
LA volume was measured at end-systole using the prolate ellipsoid model. The patients 
were categorized according to the LA volume 1 month after PMV (cutoff=60ml) Results: 
Mean follow-up duration was 8±6 years (2~20years). LA volume decreased from 94±51 
to 71±43 ml (p <0.01) 1 month after PMV. Since then, LA volume progressively increased 
over time and reached pre-PMV level at 8 years (98±55 ml) after PMV. The increase of LA 
volume over time was similarly observed regardless of age and cardiac rhythm. Clinical 
events such as death, HF, and stroke occurred in 105/319 (33%) patients. Event-free 
survival was higher in patients with small LA (18 vs.41%, p=0.01). On multiple regression 
analysis, LA volume 1 month after PMV emerged as an independent predictor of event-
free survival. Conclusions: Progressive increase of LA volume was observed even after 
successful PMV. Larger post-PMV LA volume was associated with poor prognosis. 
9:30 a.m.
1052-212 Molecular Diagnosis of Culture Negative Endocarditis 
and Intravascular Infections
Masaki Tanabe, Akiko Nakamura, Katsuya Onishi, Kaoru Dohi, Koji Onoda, Hideo 
Wada, Hideto Shimpo, Tsutomu Nobori, Masaaki Ito, Mie University Hospital, Tsu, Japan
Background:Although blood culture is important to diagnose endocarditis and 
intravascular infection, negative blood cultures are observed in some cases, especially 
after antibiotic treatment. Accordingly, our objective was to test the hypothesis that the 
utility of broad-range polymerase chain reaction (PCR) applied to whole blood can assist 
diagnosis of culture negative cardiovascular infection.
Methods:We studied 11 patients suspected of culture negative infective endocarditis (IE) 
(n=5) and intravascular infection; pacemaker infection (n=4), infected aortic aneurysm 
(n=1), and aortic graft infection (n=1). Seven of 11 cases had prior administration of 
antibiotics. We also studied 4 culture positive patients during the culture negative period 
under antibiotics; IE (n=3) and aortic graft infection (n=1). Broad-range PCR targeting 
bacterial 16S rRNA followed by direct sequencing was applied to whole blood and 
excised tissue if obtained.
Results:Bacterial broad-range PCR ampliﬁcation was positive in 5 of 11 specimens 
derived from culture negative whole blood. Streptococcus canis, Streptococcus mitis, and
Cardiobacterium sp. were identiﬁed in IE cases. Staphylococcus lugdunensis was identiﬁed 
in one of pacemaker infection case, and Legionella anisa in graft infection case. Although 
one of IE cases and infected aortic aneurysm case showed negative PCR from whole 
blood, PCR from excited tissues were positive and identiﬁed Streptococcus salivarius and
Staphylococcus aureus, respectively. One of suspected IE case and the other suspected 
pacemaker infection cases showed negative PCR from whole blood and were considered 
as non-infection. In 4 positive control cases, whole blood PCR at the culture negative phase 
was still positive, and identiﬁed same organism with blood culture.
Conclusions:Molecular diagnosis using broad-range PCR performed on whole blood 
may assist diagnosis and selection of antibiotics by identifying organisms in patients 
with culture negative endocarditis and intravascular infection. This technique may be an 
important new diagnostic tool for culture negative cardiovascular infection in the future.
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1052-209 Predictors of Echocardiographic Progression and 
Clinical Outcome in Asymptomatic Severe Aortic 
Stenosis
Duk-Hyun Kang, Ji Hye Rim, Myung-Zoon Yi, Sung-Hwan Kim, Jong-Min Song, Hyun 
Song, Kee-Joon Choi, Joo Hee Zo, Jae-Kwan Song, Jae-Won Lee, Asan Medical 
Center, Seoul, South Korea, Boramae Hospital, Seoul, South Korea
Background: We tried to identify echocardiographic predictors of clinical outcome and 
progression of stenosis in severe, asymptomatic aortic stenosis (AS).
Methods: From 1997 to 2005, we prospectively enrolled a total of consecutive 157 
patients (75 men, age;60±12 yrs) with aortic valve (AV) area < 1.0 cm2, and the exclusion 
criteria were deﬁned as the presence of angina, syncope, exertional dyspnea, ejection 
fraction < 0.50, signiﬁcant mitral valve disease and AV replacement (AVR) performed 
within 3 months of enrollment. Etiology and severity of AS, degree of AV calciﬁcation 
was evaluated by comprehensive echocardiographic examination. We assessed 
progression of AS by an increase of mean pressure gradient (PG) across AV on annual 
echocardiographic follow-up. Cardiac events were deﬁned as the occurrences of cardiac 
death, hospitalization due to congestive heart failure and AVR during follow-up.
Results: The cause of AS was rheumatic in 30 (19%), bicuspid in 54 (34%) and 
degenerative in 73 (47%) patients. During median follow-up of 62 months, there were 
17 cardiac deaths, 7 hospitalization due to congestive heart failure and 74 AVR due to 
development of symptoms or rapid progression of AS. The event-free survival rates were 
79±3% at 2 years, 57±4% at 4 years, and 39±5% at 6 years. Degree of calciﬁcation 
(hazard ratio 2.89, p=0.005) and bicuspid AV (hazard ratio 1.81, p=0.038) were 
independent variables predicting late development of cardiac events on Cox multivariate 
analysis. The rate of progression was also signiﬁcantly different according to etiology of 
AS and degree of calciﬁcation. The annual increases of PG in bicuspid and degenerative 
AS were signiﬁcantly higher than in rheumatic AS (10±16 and 9±12 mmHg, respectively 
vs. 3±4 mmHg, p<0.01 each). The rate of progression was also signiﬁcantly higher in 
patients with moderate to severe calciﬁcation (9±13 mmHg per year) compared with mild 
calciﬁcation (2±4 mmHg per year, p = 0.001).
Conclusions: The clinical outcomes were signiﬁcantly different according to etiology of 
AS and degree of calciﬁcation, and patients with bicuspid valve or moderate to severe AV 
calciﬁcation require more frequent and vigilant monitoring.
9:30 a.m.
1052-210 A Six-Month Endurance Training Program Improves LV 
Function and Increases Survival in Rats With Severe 
Aortic Regurgitation
Dominic Lachance, Eric Plante, Marie Arsenault, Jacques Couet, Laval Hospital, 
Quebec, QC, Canada
Background: Endurance aerobic training is considered beneﬁcial for most patients 
with heart disease. Intense aerobic training may result in physiologic left ventricular (LV) 
hypertrophy which shares some macroscopic similarities with pathologic LV hypertrophy 
seen in volume overload diseases such as aortic valve regurgitation (AR). It is unknown 
if aerobic training in a pathologic volume overload (AR) context will be harmful or 
beneﬁcial.
Objectives: 1. To assess the safety and the impact on survival of a 6-month treadmill 
aerobic training program in rats with severe AR. 2. To evaluate LV remodelling and 
function in AR sedentary and trained animals.
Methods: Male Wistar rats were divided in 3 groups: 1) sedentary sham-operated 
animals (Sham; n=40); 2) sedentary AR (ARS; n=70) and 3) trained AR (ART; n=34) 
animals. The training program started two weeks post-AR induction. Trained rats had 5 
training sessions/wk at an intensity gradually increasing up to 20m/s for 30 min on a 10° 
slope treadmill. A complete echocardiogram was done at baseline as well as at weeks 2, 
12 and 26 to evaluate LV size as well as systolic and diastolic function.
Results: All sham rats survived the length of the protocol comparatively to 90% and 74% 
for the ART and ARS rats, respectively (p=0.05, ARS vs. ART). Both end-diastolic and 
end-systolic diameters were smaller in ART than in ARS (p<0.0001). Ejection fraction was 
slightly better in ART than in ARS (68% vs 65% p=0.0007). The left atrium diameter was 
smaller in ART (p=0.0006 vs ARS). The diastolic function evaluated by Doppler showed 
a steeper E wave slope (p=0.0005) and an higher E/Ea ratio (p=0.0006) in untrained 
animals compared to the trained group suggesting higher ﬁlling pressures in the untrained 
group.
Conclusion: Aerobic training increased overall survival in rats with severe aortic valve 
regurgitation over a 6-month period. Trained AR rats developed less LV dilatation than 
ARS rats and seemed to improve the diastolic function.
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0920-4 Tricuspid Regurgitation in Patients With Severe Mitral 
Regurgitation and Normal Left Ventricular Ejection 
Fraction: Risk Factors and Prognostic Implications in a 
Cohort of 895 Patients
Padmini Varadarajan, Ramdas G. Pai, Loma Linda University Medical Center, Loma Linda, CA
Background: Tricuspid regurgitation (TR) is common in patients with mitral regurgitation 
(MR). But its frequency, determinants and prognostic implications in those with severe MR 
with normal LV ejection fraction are not known.
Methods: Our echocardiographic database for the period of 1993 to 2003 was screened 
for patients with severe MR and LV EF > 55%. Chart reviews were performed for clinical, 
pharmacological and surgical details. Survival was analyzed as a function of TR severity.
Results: Of the 895 patients with severe MR and normal EF, 510 (57%) had >2+TR: 2+ 
in 60%, 3+ in 29% and 4+ in 11%. Those with >2+ TR were older (age 71+16 vs. 63+17 
years, p<0.0001) and more likely to be women (63% vs.48%, p<0.0001). They also had 
a higher PA systolic pressure (53+15 vs. 40+13 mmHg, p<0.0001). After adjusting for 
group differences, >2+ TR was associated with higher mortality (RR 1.4, 95% CI. 1.1-1.8, 
p=0.02,). Mitral valve surgery with or without tricuspid repair was associated with a better 
survival in those with >2+TR (p=0.0003).
Conclusions: 1)>2+TR is frequent in patients with severe MR and normal EF and is 
associated with higher age, female gender and higher PA pressure. 2) Presence of >2+ 
TR is independently associated with higher mortality. 3) Mitral valve surgery offers a 
survival beneﬁt in these patients. 
11:00 a.m.
0920-5 Five-Year Echocardiographic Results of Restrictive 
Mitral Annuloplasty for Functional Mitral Regurgitation 
Associated With Left Ventricular Dysfunction
Satoshi Kainuma, Takenori Yokota, Koichi Toda, Kazuhiro Taniguchi, Yoshiki Sawa, Labor 
Health and Welfare Organization Osaka Rosai Hospital, Sakai, Japan, Osaka University 
Graduate School of Medicine, Suita, Japan
Background: Despite of improvements in mitral reparative techniques in the recent 
years, functional mitral regurgitation (MR) still remains a challenging surgical problem. We 
present 5-year echocardiographic results of restrictive mitral annuloplasty for functional 
MR associated with left ventricular (LV) dysfunction.
Methods: From 1999 to 2007, 49 consecutive patients (aged 62.4±9.4) with functional 
MR associated with LV dysfunction underwent restrictive mitral annuloplasty. Serial 
echocardiograms were performed to evaluate residual MR, LV end-diastolic dimension 
(LVDd), ejection fraction (EF), tenting height, coaptation length and systolic pulmonary 
arterial pressure (PAP) estimated by ﬂow velocity of tricuspid regurgitation at baseline, 
discharge, and annually thereafter.
Results: Clinical symptoms improved by NYHA class (3.4±0.6 to 1.5 ±0.7, p<0.01). 
Improvements in LV systolic function, LV reverse remodeling and systolic pulmonary 
arterial pressure were showed by serial echocardiographic studies (table). Post-operative 
recurrence of signiﬁcant MR (>grade 2) were detected in 4 patients. Tenting heights 
at baseline were longer in patients presenting recurrence of late MR than those who 
presented no residual MR (12±4 vs 8±2, p<0.01).
Conclusions: Five-year serial echocardiographic studies supported that correcting of 
functional MR resulted in continuous improvement of LV function and hemodynamic state 
in most patients with LV dysfunction. 
Serial changes of echocardiographic study after restrictive mitral annuloplasty
Baseline(n=49) Discharge(n=49) 1year(n=40)
3
year(n=19)
5
year(n=13)
LVDd(mm) 68±6 61±7* 60±7* 63±8* 64±8*
LVEF(%) 31±8 39±13* 45±15* 45±16* 40±12*
MR(grade) 3.7±0.6 0.6±0.8* 0.9±0.8* 1.4±0.9* 2.0±1.1*
Tenting height 
(mm) 8.3±2.9 4.5±2.2* 3.5±0.6* 3.6±0.8
Coaptaion
length (mm) 4.0±1.4 7.8±3.1* 8.2±1.1* 8.7±1.1*
systolic
PAP(mmHg) 57±20 34±8* 37±13* 39±19* 42±21*
* p<0.05 vs baseline
9:30 a.m.
1052-213 Sleep Disordered Breathing Is Common in Patients With 
Severe Aortic Stenosis
Christian Prinz, Olaf Oldenburg, Thomas Bitter, Dieter Horstkotte, Cornelia Piper, 
Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr 
University Bochum, Bad Oeynhausen, Germany
Background: Sleep disordered breathing (SDB) has a high prevalence and prognostic 
impact in patients (pts) with various cardiac diseases. Aim of this study was to investigate 
the prevalence of SDB in pts with severe aortic stenosis (AS).
Methods: We consecutively included 60 pts (34 men; mean age 74.3 ± 2.1 years; NYHA 
2.0 ± 0.2; BMI 23.8 ± 1.0 kg/m²) with advanced AS (AVA a 1.0 cm²). All pts achieved 
standard preoperative diagnostics, including echocardiography, cardiac catheterisation 
and in-hospital unattended cardiorespiratory polygraphy (Embletta, Embla, NL). In 
case the apnea-hypopnea-index (AHI) was > 5/h pts were considered to have SDB. If 
thoracic and abdominal inspiration efforts were documented, SDB was considered to be 
obstructive (OSA), otherwise central sleep apnea (CSA) was diagnosed.
Results: SDB was documented in 44 pts (73.3%) with an AHI of 17.6 ± 4.0/h. 14 pts (23.3 
%) had CSA (AHI: 28.8 ± 8.5/h) and 30 pts (50 %) OSA (AHI: 20.5 ± 5.5/h). Only 16 pts 
(26.7 %) demonstrated no relevant SDB. As expected, BMI was signiﬁcantly higher in pts 
with OSA (BMI 24.8 ± 1.7 kg/m²) than in pts with CSA (BMI 21.9 ± 1.3 kg/m²; p<0.01). 
Severity of SDB correlated with reduced left ventricular systolic function (EF < 55 %). 
The 16 pts (26.7%, 12 men) with myocardial decompensated severe AS had signiﬁcantly 
higher AHI of 25.6 ± 8.9/h than the 44 pts (33.3%, 22 men) with severe AS and preserved 
left ventricular function (AHI 15.2 ± 4.4, p=0.02). 44 % of all pts with EF < 55 % had CSA 
(7 pts), 50 % had OSA (8 pts) and only 6 % had no SDB (1 pt).
Conclusions: SDB has a high prevalence in pts with severe AS. In pts with higher BMI 
OSA was more frequent. Severity of SDB was higher in pts with severe AS and reduced 
EF than in pts with preserved EF. CSA was found more often (44 % vs. 23.3 %) in pts with 
decompensated AS and reduced EF.
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0920-3 Timing of Operation in Asymptomatic Mitral 
Regurgitation: A Decision Analytic Model of Quality of 
Life and Cost
Thomas H. Marwick, Myriam Hunink, University of Queensland, Brisbane, Australia
Background. Timing of surgery in chronic asymptomatic MR is controversial. We 
developed a Markov model to inform the choice between immediate surgery and a policy 
of watchful waiting in pts with asymptomatic severe MR.
Methods. Anticipated health states in MR were pre-operative, post-operative, post-
complication and death. Risks and transitions were informed by our experience and the 
literature. The implications of the strategies for survival, utility, cost and cost-effectiveness 
(CE) were calculated. Further analyses evaluated situations thought to favor early surgery 
and watchful waiting. Sensitivity analyses were based on the likelihood of death and heart 
failure (HF) in follow-up.
Results. In the reference case, the utility of watchful waiting was superior (QALY 21.44 
vs 19.70) and the cost was less ($533,886 vs 884,233) than immediate surgery. In a best 
case situation for surgery, the utility for watchful waiting was less (13.30 vs 20.68) but CE 
favored watchful waiting ($36,019/QALY vs $44,517/QALY). Sensitivity analyses showed 
immediate surgery was likely to be more effective when the yearly probability of HF in the 
watchful waiting group was >5%, but only if HF after surgery was uncommon. Likewise, 
with an expected repair mortality of 0.5-1%, immediate surgery was only more effective 
when the yearly mortality in the watchful waiting group was from 2.5-7% (Figure)
Conclusions. Immediate surgery in asymptomatic severe MR may offer worse outcomes 
at higher cost than watchful waiting. 
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0920-6 Outcome of Mildly Symptomatic or Asymptomatic 
Obstructive Hypertrophic Cardiomyopathy: A Long-
Term Follow-Up Study
Paul Sorajja, Mayo Clinic, Rochester, MN
Background. There is a subset of patients with hypertrophic cardiomyopathy (HCM) 
and severe obstruction who have few or no symptoms. The prognosis of these minimally 
symptomatic patients with obstructive HCM has not been well characterized.
Methods. We examined 544 adult patients (age, 59±16 yrs; 55% men) with obstructive 
HCM documented by Doppler echocardiography who were free of severe cardiac 
symptoms and performed clinical follow-up (median, 9.3 yrs).
Results. There was only a slight excess mortality of the cohort in comparison to the 
expected survival of a similar U.S. general population (10-year observed vs. expected 
survival, 69.3% vs. 71.9%; p=0.04) and 46% of the deaths was attributable to non-cardiac 
causes. However, there was a clear relation between increasing severity of the ventricular 
outﬂow tract gradient and outcome. For patients with high resting gradients (Doppler peak 
velocity >4 m/s), survival was signiﬁcantly impaired (53% at 10 yrs; p=0.001 vs. expected) 
and death or severe symptoms occurred in 68% of these patients within 10 years after the 
initial evaluation. Conversely, there was no impairment of long-term survival for patients 
with less severe resting obstruction. Independent predictors of mortality in the entire 
cohort were age, prior stroke, and LVOT gradient severity.
Conclusions. Patients with obstructive HCM and mild or no symptoms have only slight 
excess mortality. However, patients with markedly elevated resting LVOT gradients are at 
high risk of heart failure and death. These ﬁndings may have important implications for 
therapy, including timing of septal reduction therapy.
Key words: hypertrophic cardiomyopathy, obstruction, prognosis
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0920-7 Mitral Valve Repair in Heart Failure: Five-Year Follow-Up 
From the Mitral Valve Repair Stratum of the ACORN Trial
Mariell Jessup, Michael A. Acker, Steven Bolling, Jae Oh, Randall C. Starling, Douglas 
L. Mann, Hani N. Sabbah, Spencer Kubo, Acorn Cardiovascular, St. Paul, MN, University 
of Pennsylvania, Philadelphia, PA
Background: Many patients (pts) with mitral regurgitation (MR) and dilated 
cardiomyopathy (CM) are not referred for MVR because of concerns about the recurrence 
of MR and clinical efﬁcacy. The Acorn Randomized Trial represents the largest multicenter 
study of MVR surgery in pts with HF. We now report 5 year follow up results.
Methods: The MVR Stratum enrolled 193 pts with HF (NYHA Class III 72%; mean LVEF 
24%, mean LVEDV 270 ml) who required MVR. Patients were randomized to either Acorn 
CorCap + MVR or MVR alone. Pts had ring repair (84%) or valve replacement (16%). A 
core lab read all echocardiograms.
Results: As previously reported, 30 day mortality was 1.6%. At 5 years, total mortality 
was 30% (annual mortality rate of ~ 6% per year). At 5 years, 29 patients developed 
recurrent MR (3 or 4+ MR by echo) and 5 patients had repeat MVR (Kaplan-Meier 
cumulative estimate of 19%).
Improvements in LV end diastolic volume (LVEDV) and sphericity index were observed 
in both groups. However, the CorCap group had greater reductions in LVEDV (Fig 1) and 
greater increases in sphericity index (0.131 vs. 0.066; p<0.014) compared to control, 
suggesting that the CorCap signiﬁcantly added to MVR.
Conclusions: These long term data suggest that MVR surgery in pts with HF and CM 
is safe with a low operative mortality (1.6%), an acceptable 5 year survival rate (70%) 
and a low rate of recurrent MR. The addition of the CorCap cardiac support device to 
MVR results in signiﬁcant improvements in LV size and shape, consistent with LV reverse 
remodeling.
